öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

¡¶ÉúÎﻯѧ¡·¡ª¡ªÃû´Ê½âÊÍ´óÈ«

39055016 Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÂÛ̳/2007-09-30

Ô­ÎÄÄÚÈÝÀ´×ÔÃâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÂÛ̳£¬Çëµã»÷²é¿´È«ÎÄ
http://bbs.freekaoyan.com/viewthread.php?tid=196657
¡¶ÉúÎﻯѧ¡·¡ª¡ªÃû´Ê½âÊÍ´óÈ«
°±»ùËᣨaminoacids£©:
ÊǺ¬ÓÐÒ»¸ö¼îÐÔ°±»ùºÍÒ»¸öËáÐÔôÈ»ùµÄÓлú»¯ºÏÎ°±»ùÒ»°ãÁ¬½ÓÔÚ¦Á-̼ÉÏ¡£°±»ùËáÊÇëĺ͵°°×ÖʵĹ¹¼þ·Ö×Ó¡£
±ØÐè°±»ùËᣨessential aminoacids£©£º
Ö¸ÈË£¨»òÆäËü¼¹×µ¶¯Î×Ô¼º²»ÄܺϳÉ£¬ÐèÒª´ÓÒûʳÖлñµÃµÄ°±»ùËᣬÀýÈçÀµ°±Ëá¡¢ËÕ°±ËáµÈ°±»ùËá¡£
·Ç±ØÐè°±»ùËᣨnonessential aminoacids£©£º¡¡
Ö¸ÈË£¨»òÆäËü¼¹×µ¶¯Î×Ô¼ºÄÜÓɼòµ¥µÄǰÌåºÏ³ÉµÄ£¬²»ÐèÒªÓÉÒûʳ¹©¸øµÄ°±»ùËᣬÀýÈç¸Ê°±Ëá¡¢±û°±ËáµÈ°±»ùËá¡£
µÈµçµã£¨pI£¬isoelectric point£©£º
ʹ·Ö×Ó´¦ÓÚ¼æÐÔ·Ö×Ó״̬£¬Ôڵ糡Öв»Ç¨ÒÆ£¨·Ö×ӵľ»µçºÉΪÁ㣩µÄpHÖµ¡£ ÜáÈýͪ·´Ó¦£¨ninhydrin reaction£©£º
ÔÚ¼ÓÈÈÌõ¼þÏ£¬°±»ùËá»òëÄÓëÜáÈýͪ·´Ó¦Éú³É×ÏÉ«£¨Ó븬°±Ëá·´Ó¦Éú³É»ÆÉ«£©»¯ºÏÎïµÄ·´Ó¦¡£
ëļü£¨peptide bond£©£º
Ò»¸ö°±»ùËáµÄôÈ»ùÓëÁíÒ»¸ö°±»ùËáµÄ°±»ùËõºÏ£¬³ýÈ¥Ò»·Ö×ÓË®ÐγɵÄõ£°·¼ü¡£
ëÄ£¨peptides£©£ºÁ½¸ö»òÁ½¸öÒÔÉϰ±»ùËáͨ¹ýëļü¹²¼ÛÁ¬½ÓÐγɵľۺÏÎï¡£
µ°°×ÖÊÒ»¼¶½á¹¹(primarystructure)£ºÖ¸µ°°×ÖÊÖй²¼ÛÁ¬½ÓµÄ°±»ùËá²Ð»ùµÄÅÅÁÐ˳Ðò¡£
²ãÎö(chromatography)£º
°´ÕÕÔÚÒÆ¶¯Ïࣨ¿ÉÒÔÊÇÆøÌå»òÒºÌ壩ºÍ¹Ì¶¨Ïࣨ¿ÉÒÔÊÇÒºÌå»ò¹ÌÌ壩֮¼äµÄ·ÖÅä±ÈÀý½«»ìºÏ³É·Ö·Ö¿ªµÄ¼¼Êõ¡£
Àë×Ó½»»»²ãÎö(ion-exchange columnchromatography)£º
ʹÓôøÓй̶¨µÄ´øµç»ùÍŵľۺÏÊ÷Ö¬»òÄý½º²ãÎöÖù·ÖÀëÀë×Ó»¯ºÏÎïµÄ²ãÎö·½·¨¡£
͸Îö£¨dialysis£©£º
ͨ¹ýС·Ö×Ó¾­°ë͸ĤÀ©É¢µ½Ë®£¨»ò»º³åÒº£©µÄÔ­Àí½«Ð¡·Ö×ÓÓëÉúÎï´ó·Ö×Ó·Ö¿ªµÄÒ»ÖÖ·ÖÀë´¿»¯¼¼Êõ¡£
Äý½º¹ýÂ˲ãÎö(gelfiltration chromatography)£º
Ò²½Ð×ö·Ö×ÓÅÅ×è²ãÎö£¨molecular-exclusionchromatography£©¡£Ò»ÖÖÀûÓôø¿×Äý½ºÖé×÷»ùÖÊ£¬°´ÕÕ·Ö×Ó´óС·ÖÀëµ°°×ÖÊ»òÆäËü·Ö×Ó»ìºÏÎïµÄ²ãÎö¼¼Êõ¡£
Ç׺ͲãÎö£¨affinitychromatography£©£º
ÀûÓù²¼ÛÁ¬½ÓÓÐÌØÒìÅäÌåµÄ²ãÎö½éÖÊ·ÖÀëµ°°×ÖÊ»ìºÏÎïÖÐÄÜÌØÒì½áºÏÅäÌåµÄÄ¿µÄµ°°×»òÆäËü·Ö×ӵIJãÎö¼¼Êõ¡£
¸ßѹҺÏà²ãÎö£¨HPLC£¬high-pressure liquidchromatography£©£º
ʹÓÿÅÁ£¼«Ï¸µÄ½éÖÊ£¬ÔÚ¸ßѹÏ·ÖÀëµ°°×ÖÊ»òÆäËü·Ö×Ó»ìºÏÎïµÄ²ãÎö¼¼Êõ¡£
Äý½ºµçÓ¾£¨gelelectrophoresis£©£º
ÒÔÄý½ºÎª½éÖÊ£¬Ôڵ糡×÷ÓÃÏ·ÖÀëµ°°×ÖÊ»òºËËáµÈ·Ö×ӵķÖÀë´¿»¯¼¼Êõ¡£
SDS-¾Û±ûÏ©õ£°·Äý½ºµçÓ¾£º£¨SDS-PAGE£¬sodium dodecyl sulfate-polyacrylamide gelelectrohoresis£©
ÔÚÓÐÈ¥ÎÛ¼ÁÊ®¶þÍé»ùÁòËáÄÆ´æÔÚϵľ۱ûÏ©õ£°·Äý½ºµçÓ¾¡£SDS-PAGEÖ»Êǰ´ÕÕ·Ö×Ó´óС·ÖÀëµÄ£¬¶ø²»ÊǸù¾Ý·Ö×ÓËù´øµÄµçºÉºÍ´óС·ÖÀëµÄ¡£
µÈµç¾Û½¹µçÓ¾£¨IFE£¬isoelectric focusingelectrophoresis£©£º
ÀûÓÃÌØÊâµÄÒ»ÖÖ»º³åÒº£¨Á½ÐÔµç½âÖÊ£©ÔÚ¾Û±ûÏ©õ£°·Äý½ºÄÚÖÆÔìÒ»¸öpHÌݶÈ£¬µçӾʱÿÖÖµ°°×Öʾͽ«Ç¨ÒƵ½ËüµÄµÈµçµã£¨pI£©´¦£¬¼´ÌݶÈÖеÄijһpHʱ£¬¾Í²»ÔÙ´øÓо»µÄÕý»ò¸ºµçºÉÁË¡£
Ë«ÏòµçÓ¾£¨two-dimensionalelectrophoresis£©£º
Êǵȵç¾Û½¹µçÓ¾ºÍSDS-PAGEµÄ×éºÏ£¬¼´ÏȽøÐеȵç¾Û½¹µçÓ¾£¨°´ÕÕpI·ÖÀ룩£¬È»ºóÔÙ½øÐÐSDS-PAGE£¨°´ÕÕ·Ö×Ó´óС£©£¬¾­È¾É«µÃµ½µÄµçӾͼÊǸö¶þά·Ö²¼µÄµ°°×ÖÊͼ¡£
Edman½µ½â(Edmandegradation)£º
´Ó¶àëÄÁ´ÓÎÀëµÄNÄ©¶Ë²â¶¨°±»ùËá²Ð»ùµÄÐòÁеĹý³Ì¡£NÄ©¶Ë°±»ùËá²Ð»ù±»±½ÒìÁòÇèËáõ¥ÐÞÊΣ¬È»ºó´Ó¶àëÄÁ´ÉÏÇÐÏÂÐÞÊεIJлù£¬ÔÙ¾­²ãÎö¼ø¶¨£¬ÓàϵĶàëÄÁ´£¨ÉÙÁËÒ»¸ö²Ð»ù£©±»»ØÊÕÔÙ½øÐÐÏÂÒ»ÂÖ½µ½âÑ­»·¡£
ͬԴµ°°×ÖÊ£¨homologousproteins£©:
À´×Ô²»Í¬ÖÖÀàÉúÎï¡¢¶øÐòÁк͹¦ÄÜÀàËÆµÄµ°°×ÖÊ¡£ÀýÈçѪºìµ°°×¡£
¹¹ÐÍ£¨configuration£©£º
Ò»¸öÓлú·Ö×ÓÖи÷¸öÔ­×ÓÌØÓеĹ̶¨µÄ¿Õ¼äÅÅÁС£ÕâÖÖÅÅÁв»¾­¹ý¹²¼Û¼üµÄ¶ÏÁѺÍÖØÐÂÐγÉÊDz»»á¸Ä±äµÄ¡£¹¹Ð͵ĸıäÍùÍùʹ·Ö×ӵĹâѧ»îÐÔ·¢Éú±ä»¯¡£
¹¹Ïó£¨conformation£©£º
Ö¸Ò»¸ö·Ö×ÓÖУ¬²»¸Ä±ä¹²¼Û¼ü½á¹¹£¬½öµ¥¼üÖÜΧµÄÔ­×ÓÐýתËù²úÉúµÄÔ­×ӵĿռäÅŲ¼¡£Ò»ÖÖ¹¹Ïó¸Ä±äΪÁíÒ»ÖÖ¹¹Ïóʱ£¬²»ÒªÇó¹²¼Û¼üµÄ¶ÏÁѺÍÖØÐÂÐγÉ¡£¹¹Ïó¸Ä±ä²»»á¸Ä±ä·Ö×ӵĹâѧ»îÐÔ¡£
ëĵ¥Î»£¨peptide unit£©£º
ÓÖ³ÆÖ®ëÄ»ù£¨peptidegroup£©£¬ÊÇëÄÁ´Ö÷Á´ÉϵÄÖØ¸´½á¹¹¡£ÊÇÓɲÎÓëëļüÐγɵĵªÔ­×ÓºÍ̼ԭ×ÓºÍËüÃǵÄ4¸öÈ¡´ú³É·Ö£ºôÊ»ùÑõÔ­×Ó¡¢õ£°·ÇâÔ­×ÓºÍÁ½¸öÏàÁڵĦÁ-̼ԭ×Ó×é³ÉµÄÒ»¸öÆ½Ãæµ¥Î»¡£
µ°°×Öʶþ¼¶½á¹¹£¨protein secondarystructure£©:
ÔÚµ°°×ÖÊ·Ö×ÓÖеľֲ¿ÇøÓòÄÚ°±»ùËá²Ð»ùµÄÓйæÔòµÄÅÅÁУ¬³£¼ûµÄ¶þ¼¶½á¹¹ÓЦÁ-ÂÝÐýºÍ¦Â-ÕÛµþ¡£¶þ¼¶½á¹¹ÊÇͨ¹ý¹Ç¼ÜÉϵÄôÊ»ùºÍõ£°·»ùÍÅÖ®¼äÐγɵÄÇâ¼üά³ÖµÄ¡£
µ°°×ÖÊÈý¼¶½á¹¹£¨protein tertiarystructure£©:
µ°°×ÖÊ·Ö×Ó´¦ÓÚËüµÄÌìÈ»ÕÛµþ״̬µÄÈýά¹¹Ïó¡£Èý¼¶½á¹¹ÊÇÔÚ¶þ¼¶½á¹¹µÄ»ù´¡ÉϽøÒ»²½ÅÌÈÆ¡¢ÕÛµþÐγɵÄ¡£Èý¼¶½á¹¹Ö÷ÒªÊÇ¿¿°±»ùËá²àÁ´Ö®¼äµÄÊèË®Ï໥×÷Óá¢Çâ¼ü·¶µÂ»ªÁ¦ºÍÑμü£¨¾²µç×÷ÓÃÁ¦£©Î¬³ÖµÄ¡£µ°°×ÖÊËļ¶½á¹¹£¨quaternarystructure£©:
¶àÑÇ»ùµ°°×ÖʵÄÈýά½á¹¹¡£Êµ¼ÊÉÏÊǾßÓÐÈý¼¶½á¹¹µÄ¶àëÄÁ´£¨ÑÇ»ù£©ÒÔÊʵ±·½Ê½¾ÛºÏËù³ÊÏÖ³öµÄÈýά½á¹¹¡£
¦Á-ÂÝÐý(¦Á-helix)£º
µ°°×ÖÊÖг£¼ûµÄÒ»ÖÖ¶þ¼¶½á¹¹£¬ëÄÁ´Ö÷Á´ÈƼÙÏëµÄÖÐÐÄÖáÅÌÈÆ³ÉÂÝÐý×´£¬Ò»°ã¶¼ÊÇÓÒÊÖÂÝÐý½á¹¹£¬ÂÝÐýÊÇ¿¿Á´ÄÚÇâ¼üά³ÖµÄ¡£Ã¿¸ö°±»ùËá²Ð»ù£¨µÚn¸ö£©µÄôÊ»ùÑõÓë¶àëÄÁ´C¶Ë·½ÏòµÄµÚ4¸ö²Ð»ù£¨µÚn£«4¸ö£©µÄõ£°·µªÐγÉÇâ¼ü¡£ÔÚµäÐ͵ÄÓÒÊÖ¦Á-ÂÝÐý½á¹¹ÖУ¬ÂݾàΪ0.54nm£¬Ã¿Ò»È¦º¬ÓÐ3.6¸ö°±»ùËá²Ð»ù£¬Ã¿¸ö²Ð»ùÑØ×ÅÂÝÐýµÄ³¤ÖáÉÏÉý0.15nm¡£
¦Â-ÕÛµþ(¦Â-sheet)£º
Êǵ°°×ÖÊÖеij£¼ûµÄ¶þ¼¶½á¹¹£¬ÊÇÓÉÉìÕ¹µÄ¶àëÄÁ´×é³ÉµÄ¡£ÕÛµþƬµÄ¹¹ÏóÊÇͨ¹ýÒ»¸öëļüµÄôÊ»ùÑõºÍλÓÚͬһ¸öëÄÁ´»òÏàÁÚëÄÁ´µÄÁíÒ»¸öõ£°·ÇâÖ®¼äÐγɵÄÇâ¼üά³ÖµÄ¡£Çâ¼ü¼¸ºõ¶¼´¹Ö±ÉìÕ¹µÄëÄÁ´£¬ÕâЩëÄÁ´¿ÉÒÔÊÇÆ½ÐÐÅÅÁУ¨×ßÏò¶¼ÊÇÓÉNµ½C·½Ïò£©£»»òÕßÊÇ·´Æ½ÐÐÅÅÁУ¨ëÄÁ´·´ÏòÅÅÁУ©¡£
¦Â-ת½Ç£¨¦Â-turn£©:
Ò²ÊǶàëÄÁ´Öг£¼ûµÄ¶þ¼¶½á¹¹£¬Á¬½Óµ°°×ÖÊ·Ö×ÓÖеĶþ¼¶½á¹¹£¨¦Á-ÂÝÐýºÍ¦Â-ÕÛµþ£©£¬Ê¹ëÄÁ´×ßÏò¸Ä±äµÄÒ»ÖÖ·ÇÖØ¸´¶àëÄÇø£¬Ò»°ãº¬ÓÐ2¡«16¸ö°±»ùËá²Ð»ù¡£º¬ÓÐ5¸ö°±»ùËá²Ð»ùÒÔÉϵÄת½ÇÓÖ³£³ÆÖ®»·£¨loops£©¡£³£¼ûµÄת½Çº¬ÓÐ4¸ö°±»ùËá²Ð»ù£¬ÓÐÁ½ÖÖÀàÐÍ¡£×ª½ÇIµÄÌØµãÊÇ£ºµÚ1¸ö°±»ùËá²Ð»ùôÊ»ùÑõÓëµÚ4¸ö²Ð»ùµÄõ£°·µªÖ®¼äÐγÉÇâ¼ü£»×ª½ÇIIµÄµÚ3¸ö²Ð»ùÍùÍùÊǸʰ±Ëá¡£ÕâÁ½ÖÖת½ÇÖеĵÚ2¸ö²Ð»ù´ó¶¼ÊǸ¬°±Ëá¡£
³¬¶þ¼¶½á¹¹£¨super-secondarystructure£©£º
Ò²³ÆÖ®»ùÔª£¨motif£©¡£ÔÚµ°°×ÖÊÖУ¬ÌرðÊÇÇòµ°°×ÖУ¬¾­³£¿ÉÒÔ¿´µ½ÓÉÈô¸ÉÏàÁڵĶþ¼¶½á¹¹µ¥Ôª×éºÏÔÚÒ»Æð£¬±Ë´ËÏ໥×÷Óã¬ÐγɵÄÓйæÔò¡¢ÔÚ¿Õ¼äÉÏÄܱæÈϵĶþ¼¶½á¹¹×éºÏÌå¡£
½á¹¹Óò(domain)£º
ÔÚµ°°×ÖÊÈý¼¶½á¹¹ÄڵĶÀÁ¢ÕÛµþµ¥Ôª¡£½á¹¹Óòͨ³£¶¼ÊǼ¸¸ö³¬¶þ¼¶½á¹¹µ¥ÔªµÄ×éºÏ¡£
ÏËάµ°°×(fibrousproteins)£º
Ò»ÀàÖ÷ÒªµÄ²»ÈÜÓÚË®µÄµ°°×ÖÊ£¬Í¨³£¶¼º¬ÓгÊÏÖÏàͬ¶þ¼¶½á¹¹µÄ¶àëÄÁ´¡£Ðí¶àÏËάµ°°×½áºÏ½ôÃÜ£¬²¢Îªµ¥¸öϸ°û»òÕû¸öÉúÎïÌåÌṩ»úеǿ¶È£¬Æð×ű£»¤»ò½á¹¹ÉϵÄ×÷Óá£
Çòµ°°×(globularproteins)£º
Ò»À൰°×ÖÊ£¬Ðí¶à¶¼ÈÜÓÚË®£¬Çòµ°°×Êǽô´ÕµÄ¡¢½üËÆÇòÐεÄ¡¢º¬ÓÐÕÛµþ½ôÃܵĶàëÄÁ´¡£µäÐ͵ÄÇòµ°°×º¬ÓÐÄÜÌØÒìʶ±ðºÍ½áºÏÆäËü»¯ºÏÎïµÄ°¼ÏÝ»òÁÑ϶²¿Î»¡£
½Çµ°°×£¨keratins£©£º
ÓÉ´¦ÓÚ¦Á-ÂÝÐý»ò¦Â-ÕÛµþ¹¹ÏóµÄƽÐеĶàëÄÁ´×é³ÉµÄ²»ÈÜÓÚË®µÄÆð×ű£»¤»ò½á¹¹×÷Óõĵ°°×ÖÊ¡£
½ºÔ­£¨µ°°×£©£¨collagen£©£º
ÊǶ¯Îï½áµÞ×éÖ¯ÖÐ×î·á¸»µÄÒ»Öֽṹµ°°×£¬ËüÊÇÓÉÔ­½ºÔ­µ°°×·Ö×Ó×é³É£¬Ô­½ºÔ­µ°°×ÊÇÒ»ÖÖ¾ßÓÐÓÒÊÖ³¬ÂÝÐý½á¹¹µÄµ°°×¡£Ã¿¸öÔ­½ºÔ­·Ö×Ó¶¼ÊÇÓÉ3ÌõÌØÊâµÄ×óÊÖÂÝÐý£¨Âݾà0.95nm£¬Ã¿Ò»È¦º¬ÓÐ3.3¸ö²Ð»ù£©µÄ¶àëÄÁ´ÓÒÊÖÐýתÐγɵÄ¡£
ÊèË®Ï໥×÷ÓÃ(hydrophobicinteraction)£º
·Ç¼«ÐÔ·Ö×ÓÖ®¼äµÄÒ»ÖÖÈõµÄ¡¢·Ç¹²¼ÛµÄÏ໥×÷Óá£ÕâЩ·Ç¼«ÐÔ·Ö×Ó£¨ÈçһЩÖÐÐÔ°±»ùËá²Ð»ù£¬Ò²³ÆÖ®ÊèË®²Ð»ù£©ÔÚË®Ïà»·¾³ÖоßÓбܿªË®¶øÏ໥¾Û¼¯µÄÇãÏò¡£
°éÄïµ°°×£¨chaperone£©£º
ÓëÒ»ÖÖкϳɵĶàëÄÁ´Ðγɸ´ºÏÎﲢЭÖúËüÕýÈ·ÕÛµþ³É¾ßÓÐÉúÎ﹦Äܹ¹ÏóµÄµ°°×ÖÊ¡£°éÄïµ°°×¿ÉÒÔ·ÀÖ¹²»ÕýÈ·ÕÛµþÖмäÌåµÄÐγɺÍûÓÐ×é×°µÄµ°°×ÑÇ»ùµÄ²»ÕýÈ·µÄ¾Û¼¯£¬Ð­Öú¶àëÄÁ´¿çĤתÔËÒÔ¼°´óµÄ¶àÑÇ»ùµ°°×ÖʵÄ×é×°ºÍ½âÌå¡£
¶þÁò¼ü£¨disulfide bond£©£º
ͨ¹ýÁ½¸ö£¨°ëë×°±ËᣩÛÏ»ùµÄÑõ»¯ÐγɵĹ²¼Û¼ü¡£¶þÁò¼üÔÚÎȶ¨Ä³Ð©µ°°×µÄÈýά½á¹¹ÉÏÆð×ÅÖØÒªµÄ×÷Óá£
·¶µÂ»ªÁ¦£¨van der Waalsforce£©£º
ÖÐÐÔÔ­×ÓÖ®¼äͨ¹ý˲¼ä¾²µçÏ໥×÷ÓòúÉúµÄÒ»ÖÖÈõµÄ·Ö×ÓÖ®¼äµÄÁ¦¡£µ±Á½¸öÔ­×ÓÖ®¼äµÄ¾àÀëΪËüÃǵķ¶µÂ»ª°ë¾¶Ö®ºÍʱ£¬·¶µÂ»ªÒýÁ¦×îÇ¿¡£Ç¿µÄ·¶µÂ»ªÅųâ×÷ÓÿÉÒÔ·ÀÖ¹Ô­×ÓÏ໥¿¿½ü¡£
µ°°×ÖʱäÐÔ£¨denaturation£©£º
ÉúÎï´ó·Ö×ÓµÄÌìÈ»¹¹ÏóÔâµ½ÆÆ»µµ¼ÖÂÆäÉúÎï»îÐÔɥʧµÄÏÖÏó¡£µ°°×ÖÊÔÚÊܵ½¹âÕÕ¡¢ÈÈ¡¢ÓлúÈܼÁÒÔ¼°Ò»Ð©±äÐÔ¼ÁµÄ×÷ÓÃʱ£¬´Î¼¶¼üÊܵ½ÆÆ»µ£¬µ¼ÖÂÌìÈ»¹¹ÏóµÄÆÆ»µ£¬Ê¹µ°°×ÖʵÄÉúÎï»îÐÔɥʧ¡£
¸´ÐÔ£¨renaturation£©£º
ÔÚÒ»¶¨µÄÌõ¼þÏ£¬±äÐÔµÄÉúÎï´ó·Ö×Ó»Ö¸´³É¾ßÓÐÉúÎï»îÐÔµÄÌìÈ»¹¹ÏóµÄÏÖÏó¡£
¼¡ºìµ°°×£¨myoglobin£©£º
ÊÇÓÉÒ»ÌõëÄÁ´ºÍÒ»¸öѪºìËØ¸¨»ù×é³ÉµÄ½áºÏµ°°×£¬ÊǼ¡ÈâÄÚ´¢´æÑõµÄµ°°×ÖÊ£¬ËüµÄÑõ±¥ºÍÇúÏßΪ˫ÇúÏßÐÍ¡£
Ѫºìµ°°×£¨hemoglobin£©£º
ÊÇÓɺ¬ÓÐѪºìËØ¸¨»ùµÄ4¸öÑÇ»ù×é³ÉµÄ¹Ñ¾Ûµ°°×¡£Ñªºìµ°°×¸ºÔð½«ÑõÓÉ·ÎÔËÊäµ½ÍâÖÜ×éÖ¯£¬ËüµÄÑõ±¥ºÍÇúÏßΪSÐÍ¡£
²¨¶ûЧӦ£¨Bohr effect£©£º
CO2Ũ¶ÈµÄÔö¼Ó½µµÍϸ°ûÄÚµÄpH£¬ÒýÆðºìϸ°ûÄÚѪºìµ°°×µÄÑõÇ׺ÍÁ¦Ï½µµÄÏÖÏó¡£
±ð¹¹Ð§Ó¦£¨allostericeffect£©£º
ÓÖ³ÆÖ®±ä¹¹Ð§Ó¦¡£ÊǹѾ۵°°×ÓëÅä»ù½áºÏ¸Ä±äµ°°×ÖʵĹ¹Ï󣬵¼Öµ°°×ÖÊÉúÎï»îÐԸıäµÄÏÖÏó¡£
Á­µ¶ÐÍϸ°ûƶѪ²¡£¨sickle-cellanemia£©£ºÑªºìµ°°×·Ö×ÓÒÅ´«È±ÏÝÔì³ÉµÄÒ»ÖÖ¼²²¡£¬²¡È˵Ĵ󲿷ֺìϸ°û³ÊÁ­µ¶×´¡£ÆäÌØµãÊDz¡È˵ÄѪºìµ°°×¦Â-ÑÇ»ùN¶ËµÄµÚ6¸ö°±»ùËá²Ð»ùÊÇçÓ°±Ëᣬ¶ø²»ÊÇÕý³£µÄ¹È°±Ëá²Ð»ù¡£
ø£¨enzyme£©:
ÉúÎï´ß»¯¼Á£¬³ýÉÙÊýRNAÍ⼸ºõ¶¼Êǵ°°×ÖÊ¡£Ã¸²»¸Ä±ä·´Ó¦µÄƽºâ£¬Ö»ÊÇͨ¹ý½µµÍ»î»¯Äܼӿ췴ӦµÄËÙ¶È¡£
ȫø£¨holoenzyme£©£º
¾ßÓд߻¯»îÐÔµÄø£¬°üÀ¨ËùÓеıØÐèµÄÑÇ»ù¡¢¸¨»ùºÍÆäËüµÄ¸¨ÖúÒò×Ó¡£
ÍѸ¨»ùøµ°°×£¨apoenzyme£©£º
øÖгýÈ¥´ß»¯»îÐÔ¿ÉÄÜÐèÒªµÄÓлú»òÎÞ»ú¸¨ÖúÒò×Ó»ò¸¨»ùºóµÄµ°°×Öʲ¿·Ö¡£
ø»îÁ¦µ¥Î»£¨U£¬activeunit£©£º
ø»îÁ¦µÄ¶ÈÁ¿µ¥Î»¡£1961Äê¹ú¼Êøѧ»áÒ鹿¶¨£º1¸öø»îÁ¦µ¥Î»ÊÇÖ¸ÔÚÌØ¶¨Ìõ¼þ£¨25¡æ£¬ÆäËüΪ×îÊÊÌõ¼þ£©Ï£¬ÔÚ1·ÖÖÓÄÚÄÜת»¯1΢Ħ¶ûµ×ÎïµÄøÁ¿£¬»òÊÇת»¯µ×ÎïÖÐ1΢Ħ¶ûµÄÓйػùÍŵÄøÁ¿¡£
±È»î(specific activity)£º
ÿ·ÖÖÓÿºÁ¿Ëøµ°°×ÔÚ25¡æÏÂת»¯µÄµ×ÎïµÄ΢Ħ¶ûÊý£¨¦Ìm£©¡£±È»îÊÇø´¿¶ÈµÄ²âÁ¿¡£
»î»¯ÄÜ£¨activation energy£©£º½«Ò»Ä¦¶û·´Ó¦µ×ÎïÖеÄËùÓзÖ×ÓÓÉ»ù̬ת»¯Îª¹ý¶É̬ËùÐèÒªµÄÄÜÁ¿¡£
»îÐÔ²¿Î»£¨activesite£©:
øÖк¬Óе×Îï½áºÏ²¿Î»ºÍ²ÎÓë´ß»¯µ×Îïת»¯Îª²úÎïµÄ°±»ùËá²Ð»ùµÄ²¿·Ö¡£»îÐÔ²¿Î»Í¨³£¶¼Î»ÓÚµ°°×ÖʵĽṹÓò»òÑÇ»ùÖ®¼äµÄÁÑ϶»òÊǵ°°×ÖʱíÃæµÄ°¼Ïݲ¿Î»£¬Í¨³£¶¼ÊÇÓÉÔÚÈýά¿Õ¼äÉÏ¿¿µÃºÜ½üµÄһЩ°±»ùËá²Ð»ù×é³ÉµÄ¡£
Ëá-¼î´ß»¯£¨acid-base catalysis£©£ºÖÊ×Ó×ªÒÆ¼ÓËÙ·´Ó¦µÄ´ß»¯×÷Ó᣹²¼Û´ß»¯£¨covalentcatalysis£©£º
Ò»¸öµ×Îï»òµ×ÎïµÄÒ»²¿·ÖÓë´ß»¯¼ÁÐγɹ²¼Û¼ü£¬È»ºó±»×ªÒƸøµÚ¶þ¸öµ×Îï¡£Ðí¶àø´ß»¯µÄ»ùÍÅ×ªÒÆ·´Ó¦¶¼ÊÇͨ¹ý¹²¼Û´ß»¯·½Ê½½øÐеÄ¡£
¿¿½üЧӦ£¨proximityeffect£©£º
·Çø´Ù·´Ó¦»òø´Ù·´Ó¦ËÙÂʵÄÔö¼ÓÊÇÓÉÓÚ»îÐÔ²¿Î»´¦·´Ó¦¼ÁÓÐЧŨ¶ÈÔö´ó£¨µ×Îï¿¿½ü»îÐÔ²¿Î»£©µÄ½á¹û£¬Õ⽫µ¼Ö¸üƵ·±µØÐγɹý¶É̬¡£
³õËÙ¶È(initial velocity)£º
ø´Ù·´Ó¦×î³õ½×¶Îµ×Îïת»¯Îª²úÎïµÄËÙ¶È£¬ÕâÒ»½×¶Î²úÎïµÄŨ¶È·Ç³£µÍ£¬ÆäÄæ·´Ó¦¿ÉÒÔºöÂÔ²»¼Æ¡£
Ã×ÊÏ·½³Ì£¨Michaelis-Mentenequation£©:
±íʾһ¸öø´Ù·´Ó¦µÄÆðʼËÙ¶È£¨v£©Óëµ×ÎïŨ¶È£¨[S]£©¹ØÏµµÄËÙ¶È·½³Ì£¬v£½Vmax[S]/£¨Km [S]£©¡£
Ã×Êϳ£Êý£¨Michaelisconstant,£©£¨Km£©£º
¶ÔÓÚÒ»¸ö¸ø¶¨·´Ó¦£¬µ¼ÖÂø´Ù·´Ó¦ËÙ¶ÈµÄÆðʼËÙ¶È£¨v0£©´ïµ½×î´ó·´Ó¦ËÙ¶È£¨Vmax£©Ò»°ëʱµÄµ×ÎïŨ¶È¡£
´ß»¯³£Êý£¨catalytic number£©£¨Kcat£©:
Ò²³ÆÖ®×ª»»Êý(turnovernumber)¡£Ò»¸ö¶¯Á¦Ñ§³£Êý£¬ÊÇÔÚµ×ÎïŨ¶È´¦ÓÚ±¥ºÍ״̬Ï£¬Ò»¸öø£¨»òÒ»¸öø»îÐÔ²¿Î»£©´ß»¯Ò»¸ö·´Ó¦Óжà¿ìµÄ²âÁ¿¡£´ß»¯³£ÊýµÈÓÚ×î´ó·´Ó¦ËٶȳýÒÔ×ܵÄøŨ¶È£¨Vmax/[E]total£©£¬»òÕßÊÇÿĦ¶ûø»îÐÔ²¿Î»Ã¿ÃëÖÓת»¯Îª²úÎïµÄµ×ÎïµÄĦ¶ûÊý¡£
Ë«µ¹Êý×÷ͼ£¨double-reciprocalplot£©:
Ò²³ÆÖ®Lineweaver-Burk×÷ͼ¡£Ò»¸öø´Ù·´Ó¦Ëٶȵĵ¹Êý£¨1/v£©¶Ôµ×ÎïŨ¶ÈµÄµ¹Êý£¨1/[s]£©µÄ×÷ͼ¡£XºÍyÖáÉϵĽؾà·Ö±ð´ú±íÃ×Êϳ£Êý£¨Km£©ºÍ×î´ó·´Ó¦ËÙ¶È£¨Vmax£©µÄµ¹Êý¡£
¾ºÕùÐÔÒÖÖÆ×÷Óã¨competitiveinhibition£©£º
ͨ¹ýÔö¼Óµ×ÎïŨ¶È¿ÉÒÔÄæ×ªµÄÒ»ÖÖøÒÖÖÆÀàÐÍ¡£Ò»¸ö¾ºÕùÐÔÒÖÖÆ¼Áͨ³£ÓëÕý³£µÄµ×Îï»òÅäÌ徺Õùͬһ¸öµ°°×ÖʵĽáºÏ²¿Î»¡£ÕâÖÖÒÖÖÆÊ¹µÃKmÔö´ó£¬¶øVmax²»±ä¡£
·Ç¾ºÕùÐÔÒÖÖÆ×÷Óã¨noncompetitiveinhibition£©£º
ÒÖÖÆ¼Á²»½öÓëÓÎÀëø½áºÏ£¬Ò²¿ÉÒÔÓëø-µ×Î︴ºÏÎï½áºÏµÄÒ»ÖÖø´Ù·´Ó¦ÒÖÖÆ×÷Óá£ÕâÖÖÒÖÖÆÊ¹µÃVmax±äС£¬µ«Km²»±ä¡£
·´¾ºÕùÐÔÒÖÖÆ×÷Óã¨uncompetitiveinhibition£©£º
ÒÖÖÆ¼ÁÖ»Óëø-µ×Î︴ºÏÎï½áºÏ£¬¶ø²»ÓëÓÎÀëø½áºÏµÄÒ»ÖÖø´Ù·´Ó¦ÒÖÖÆ×÷Óá£ÕâÖÖÒÖÖÆ×÷ÓÃʹµÃVmax£¬Km¶¼±äС£¬µ«Vmax/Km±ÈÖµ²»±ä¡£
Ë¿°±Ëáµ°°×ø£¨serine protease£©£º»îÐÔ²¿Î»º¬ÓÐÔÚ´ß»¯ÆÚ¼äÆð×ÅÇ׺ËÌå×÷ÓõÄË¿°±Ëá²Ð»ùµÄµ°°×ø¡£
øԭ£¨zymogen£©£ºÍ¨¹ýÓÐÏÞµ°°×Ë®½âÄܹ»ÓÉÎÞ»îÐÔ±ä³É¾ßÓд߻¯»îÐÔµÄøǰÌå¡£
µ÷½Úø£¨regulatoryenzyme£©£ºÎ»ÓÚÒ»¸ö»ò¶à¸ö´úл;¾¶ÄÚµÄÒ»¸ö¹Ø¼ü²¿Î»µÄø£¬ËüµÄ»îÐÔ¸ù¾Ý´úлµÄÐèÒª±»Ôö¼Ó»ò½µµÍ¡£
±ð¹¹Ã¸£¨allostericenzyme£©£ºÒ»ÖÖÆä»îÐÔÊܵ½½áºÏÔÚ»îÐÔ²¿Î»ÒÔÍⲿλµÄÆäËü·Ö×Óµ÷½ÚµÄø¡£
±ð¹¹µ÷½Ú¼Á£¨allostericmodulator£©:
½áºÏÔÚ±ð¹¹Ã¸µÄµ÷½Ú²¿Î»µ÷½Ú¸Ãø´ß»¯»îÐÔµÄÉúÎï·Ö×Ó£¬±ð¹¹µ÷½Ú¼Á¿ÉÒÔÊǼ¤»î¼Á£¬Ò²¿ÉÒÔÊÇÒÖÖÆ¼Á¡£
Æë±äģʽ£¨concertedmodel£©£º
ÏàͬÅäÌåÓë¹Ñ¾Ûµ°°×Эͬ½áºÏµÄÒ»ÖÖģʽ¡£°´ÕÕ×î¼òµ¥Æë±äģʽ£¬ÓÉÓÚÒ»¸öµ×Îï»ò±ð¹¹µ÷½Ú¼ÁµÄ½áºÏ£¬µ°°×ÖʵĹ¹ÏóÔÚT£¨¶Ôµ×ÎïÇ׺ÍÐԵ͵Ĺ¹Ï󣩺ÍR£¨¶Ôµ×ÎïÇ׺ÍÐԸߵĹ¹Ïó£©Ö®¼ä±ä»»¡£ÕâһģʽÌá³öËùÓе°°×ÖʵÄÑÇ»ù¶¼¾ßÓÐͬÑùµÄ¹¹Ï󣬻òÊÇT£¬»òÊÇR¹¹Ïó¡£
Ðò±äģʽ£¨sequentialmodel£©£º
ÏàͬÅäÌåÓë¹Ñ¾Ûµ°°×Эͬ½áºÏµÄÁíÍâÒ»ÖÖģʽ¡£°´ÕÕ×î¼òµ¥µÄÐò±äģʽ£¬Ò»¸öÅäÌåµÄ½áºÏ»áÓÕµ¼Ëü½áºÏµÄÑÇ»ùµÄÈý¼¶½á¹¹µÄ±ä»¯£¬ÒÔ¼°Ê¹ÏàÁÚÑÇ»ùµÄ¹¹Ïó·¢ÉúºÜ´óµÄ±ä»¯¡£°´ÕÕÐò±äģʽ£¬Ö»ÓÐÒ»¸öÑÇ»ù¶ÔÅäÌå¾ßÓиߵÄÇ׺ÍÐÔ¡£
ͬ¹¦Ã¸(isoenzyme»òisozyme)£º
´ß»¯Í¬Ò»»¯Ñ§·´Ó¦¶ø»¯Ñ§×é³É²»Í¬µÄÒ»×éø¡£ËüÃDZ˴ËÔÚ°±»ùËáÐòÁС¢µ×ÎïµÄÇ׺ÍÐԵȷ½Ãæ¶¼´æÔÚ×ŲîÒì¡£
±ð¹¹µ÷½ÚÎï(allosteric modulator)£º
Ò²³ÆÖ®±ð¹¹Ð§Ó¦Îallostericeffector£©¡£½áºÏÔÚ±ð¹¹Ã¸µÄµ÷½Ú²¿Î»£¬µ÷½Úø´ß»¯»îÐÔµÄÉúÎï·Ö×Ó¡£±ð¹¹µ÷½ÚÎï¿ÉÒÔÊǼ¤»î¼Á»òÒÖÖÆ¼Á
άÉúËØ(vitamin)£º
ÊÇÒ»ÀදÎï±¾Éí²»Äܺϳɵ«¶Ô¶¯ÎïÉú³¤ºÍ½¡¿µÓÖÊDZØÐèµÄÓлú»¯ºÏÎËùÒÔ±ØÐë´ÓÒûʳÖлñµÃ¡£Ðí¶à¸¨Ã¸¶¼ÊÇÓÉάÉúËØÑÜÉúµÄ¡£
Ë®ÈÜÐÔάÉúËØ£¨water-solublevitamins£©£º
Ò»ÀàÄÜÈÜÓÚË®µÄÓлúÓªÑø·Ö×Ó¡£ÆäÖаüÀ¨ÔÚøµÄ´ß»¯ÖÐÆð×ÅÖØÒª×÷ÓõÄB×åάÉúËØÒÔ¼°¿¹»µÑªËᣨάÉúËØC£©µÈ¡£

Ö¬ÈÜÐÔάÉúËØ£¨lipidvitamins£©£º
Óɳ¤µÄ̼ÇâÁ´»ò³í»·×é³ÉµÄ¾ÛÎì¶þÏ©»¯ºÏÎï¡£Ö¬ÈÜÐÔάÉúËØ°üÀ¨Î¬ÉúËØA¡¢D¡¢EºÍK£¬ÕâÀàάÉúËØÄܱ»¶¯ÎïÖü´æ¡£
¸¨Ã¸£¨coenzyme£©£º
ijЩøÔÚ·¢»Ó´ß»¯×÷ÓÃʱËùÐèÒªµÄÒ»ÀศÖúÒò×Ó£¬Æä³É·ÖÖÐÍùÍùº¬ÓÐάÉúËØ¡£
¸¨»ù(prostheticgroup)£º
ÊÇÓëøµ°°×¹²¼Û½áºÏµÄ½ðÊôÀë×Ó»òÒ»ÀàÓлú»¯ºÏÎÓÃ͸Îö·¨²»ÄܳýÈ¥¡£¸¨»ùÔÚÕû¸öø´Ù·´Ó¦¹ý³ÌÖÐʼÖÕÓëøµÄÌØ¶¨²¿Î»½áºÏ¡£
Äá¿Ëõ£°·ÏÙàÑßʶþºËÜÕËáºÍÄá¿Ëõ£°·ÏÙàÑßʶþºËÜÕËáÁ×Ëá
£¨NADP£«£¬nicotinamide adenine dinucleotidephosphate£©£º
º¬ÓÐÄá¿Ëõ£°·µÄ¸¨Ã¸£¬ÔÚijЩÑõ»¯»¹Ô­·´Ó¦ÖÐÆð×ÅÇâÔ­×Ӻ͵ç×ÓÔØÌåµÄ×÷Ó㬳£³£×÷ΪÍÑÇâøµÄ¸¨Ã¸¡£
»ÆËص¥ºËÜÕËᣨFMN,flavin mononucleotide£©£ººË»ÆËØÁ×ËᣬÊÇijЩÑõ»¯»¹Ô­Ã¸µÄ¸¨Ã¸¡£
»ÆËØÏÙàÑßʶþºËÜÕËᣨFAD, flavinadenine dinucleotide£©£º
ÊÇijЩÑõ»¯»¹Ô­Ã¸µÄ¸¨Ã¸£¬º¬Óк˻ÆËØ¡£
Áò°·Ëؽ¹Á×Ëᣨthiaminepyrophosphate£©£ºÊÇάÉúËØB1µÄ¸¨Ã¸ÐÎʽ£¬²ÎÓëתȩ»ù·´Ó¦¡£
Á×ËáßÁ¶ßÈ©£¨pyidoxalphosphate£©£º
ÊÇάÉúËØB6£¨ßÁ¶ß´¼£©µÄÑÜÉúÎÊÇת°±Ã¸¡¢ÍÑôÈøºÍÏûÐýøµÄ¸¨Ã¸¡£
ÉúÎïËØ£¨biotin£©£º²ÎÓëÍÑôÈ·´Ó¦µÄÒ»ÖÖøµÄ¸¨ÖúÒò×Ó¡£
¸¨Ã¸A£¨coenzymeA£©£ºÒ»ÖÖº¬ÓзºËáµÄ¸¨Ã¸£¬ÔÚijЩø´Ù·´Ó¦ÖÐ×÷Ϊõ£»ùµÄÔØÌå¡£
ÀàºúÂܲ·ËØ£¨carotenoids£©:ÓÉÒìÎì¶þÏ©×é³ÉµÄÖ¬ÈÜÐÔ¹âºÏÉ«ËØ¡£
ת°±Ã¸£¨transaminases£©£ºÒ²³ÆÖ®°±»ù×ªÒÆÃ¸£¨aminotransferases£©£¬ÔÚ¸ÃøµÄ´ß»¯ÏÂÒ»¸ö¦Á-°±»ùËáµÄ°±»ùת¿ÉÒÆ¸øÁíÒ»¸ö¦Á-ͪËá¡£
È©ÌÇ£¨aldoses£©£ºÒ»À൥ÌÇ£¬¸Ãµ¥ÌÇÖÐÑõ»¯Êý×î¸ßµÄ̼ԭ×Ó£¨Ö¸¶¨ÎªC-1£©ÊǸöÈ©»ù¡£
ͪÌÇ£¨ketoses£©£ºÒ»À൥ÌÇ£¬¸Ãµ¥ÌÇÖÐÑõ»¯Êý×î¸ßµÄ̼ԭ×Ó£¨Ö¸¶¨ÎªC-2£©ÊǸöͪ»ù¡£
ÒìÍ·Îanomers£©:½öÔÚÑõ»¯Êý×î¸ßµÄ̼ԭ×Ó£¨Òìͷ̼£©¾ßÓв»Í¬¹¹Ð͵ÄÌÇ·Ö×ÓµÄÁ½ÖÖÒì¹¹Ìå¡£
Òìͷ̼£¨anomericcarbon£©£ºÒ»¸ö»·»¯µ¥ÌǵÄÑõ»¯Êý×î¸ßµÄ̼ԭ×Ó¡£Òìͷ̼¾ßÓÐÒ»¸öôÊ»ùµÄ»¯Ñ§·´Ó¦ÐÔ¡£
±äÐý£¨mutarotation£©:Ò»¸ößÁà«ÌÇ¡¢ß»à«ÌÇ»òÌÇÜÕ°éËæ×ÅËüÃǵĦÁ-ºÍ¦Â-Òì¹¹ÐÎʽµÄƽºâ¶ø·¢ÉúµÄ±ÈÐý¶È±ä»¯¡£
µ¥ÌÇ£¨monosaccharide£©£ºÓÉÈý¸ö»ò¸ü¶à̼ԭ×Ó×é³ÉµÄ¾ßÓо­Ñ鹫ʽ£¨CH2O£©nµÄ¼òµ¥ÌÇ¡£
ÌÇÜÕ(glycosides)£ºµ¥ÌǰëËõÈ©ôÇ»ùÓëÁíÒ»¸ö·Ö×Ó£¨ÀýÈç´¼¡¢ÌÇ¡¢àÑßÊ»òà×ण©µÄôÇ»ù¡¢°·»ù»òÛÏ»ùËõºÏÐγɵĺ¬ÌÇÑÜÉúÎï¡£
ÌÇÜÕ¼ü(glycosidicbond)£ºÒ»¸öÌǰëËõÈ©ôÇ»ùÓëÁíÒ»¸ö·Ö×Ó£¨ÀýÈç´¼¡¢ÌÇ¡¢àÑßÊ»òà×ण©µÄôÇ»ù¡¢°·»ù»òÛÏ»ùÖ®¼äËõºÏÐγɵÄËõÈ©»òËõͪ¼ü£¬³£¼ûµÄÌÇÜÕ¼üÓÐO-ÌÇÜÕ¼üºÍN-ÌÇÜÕ¼ü¡£
¹ÑÌÇ£¨oligoccharide£©£ºÓÉ2¸ö¡«20¸öµ¥ÌDzлùͨ¹ýÌÇÜÕ¼üÁ¬½ÓÐγɵľۺÏÎï¡£
¶àÌÇ£¨polysaccharide£©£º20¸öÒÔÉϵĵ¥ÌÇͨ¹ýÌÇÜÕ¼üÁ¬½ÓÐγɵľۺÏÎï¡£¶àÌÇÁ´¿ÉÒÔÊÇÏßÐԵĻò´øÓзÖÖ§µÄ¡£
»¹Ô­ÌÇ£¨reducing sugar£©£ºôÊ»ù̼£¨Òìͷ̼£©Ã»ÓвÎÓëÐγÉÌÇÜÕ¼ü£¬Òò´Ë¿É±»Ñõ»¯³äµ±»¹Ô­¼ÁµÄÌÇ¡£
µí·Û£¨starch£©£ºÒ»Àà¿É×÷ΪֲÎïÖÐÖü´æ¶àÌÇµÄÆÏÌÑÌDzлùµÄͬ¾ÛÎï¡£ÓÉÁ½ÖÖÐÎʽµÄµí·Û£ºÒ»ÖÖÊÇÖ±Á´µí·Û£¬ÊÇûÓзÖÖ§µÄÖ»ÊÇͨ¹ý¦Á-£¨1¡ú4£©ÌÇÜÕ¼üÁ¬½ÓµÄÆÏÌÑÌDzлù¾ÛºÏÎï¡£ÁíÒ»ÖÖÊÇÖ§Á´µí·Û£¬ÊǺ¬ÓзÖÖ§µÄ¦Á-£¨1¡ú4£©ÌÇÜÕ¼üÁ¬½ÓµÄÆÏÌÑÌDzлù¾ÛºÏÎ֧Á´ÔÚ·ÖÖ§µã´¦Í¨¹ý¦Á-£¨1¡ú6£©ÌÇÜÕ¼üÓëÖ÷Á´ÏàÁ¬¡£
ÌÇÔ­£¨glycogen£©£ºÊǺ¬ÓзÖÖ§µÄ¦Á-£¨1¡ú4£©ÌÇÜÕ¼üÁ¬½ÓÔÚÒ»ÆðµÄÆÏÌÑÌǵÄͬ¾ÛÎ֧Á´ÔÚ·ÖÖ§µã´¦Í¨¹ý¦Á-£¨1¡ú6£©ÌÇÜÕ¼üÓëÖ÷Á´ÏàÁ¬¡£
¼«ÏÞºý¾«£¨limitdexitrin£©:ÊÇÖ¸Ö§Á´µí·ÛÖдøÓÐÖ§Á´µÄºËÐIJ¿·Ö£¬¸Ã²¿·ÖÔÚÖ§Á´µí·Û¾­µí·Ûøˮ½â×÷Óá¢ÌÇÔ­Á×Ëữø»òµí·ÛÁ×Ëữø×÷ÓúóÈÔÈ»´æÔÚ¡£ºý¾«µÄ½øÒ»²½½µ½âÐèÒª¦Á£¨1¡ú6£©ÌÇÜÕ¼üµÄË®½â¡£
ëľÛÌÇ£¨peptidoglycan£©£ºN-ÒÒõ£ÆÏÌÑÌǰ·ºÍN-ÒÒõ£ÍÙÒºËá½»ÌæÁ¬½ÓµÄÔÓ¶àÌÇÓ벻ͬ×é³ÉµÄ뼻²æÁ¬½ÓÐγɵĴó·Ö×Ó¡£ëľÛÌÇÊÇÐí¶àϸ¾úϸ°û±ÚµÄÖ÷Òª³É·Ö¡£
Ìǵ°°×£¨glycoprotein£©£ºº¬Óй²¼ÛÁ¬½ÓµÄÆÏÌÑÌDzлùµÄµ°°×ÖÊ¡£
µ°°×¾ÛÌÇ£¨proteoglycans£©£ºÓÉÔÓ¶àÌÇÓëÒ»¸ö¶àëÄÁ´×é³ÉµÄÔÓ»¯µÄ´ó·Ö×Ó£¬¶àÌÇÊÇ·Ö×ÓµÄÖ÷Òª³É·Ö¡£
Ö¬·¾Ëᣨfattyacid£©£ºÊÇÖ¸Ò»¶Ëº¬ÓÐÒ»¸öôÈ»ùµÄ³¤µÄÖ¬·¾×å̼ÇâÁ´¡£Ö¬·¾ËáÊÇ×î¼òµ¥µÄÒ»ÖÖÖ¬£¬ËüÊÇÐí¶à¸ü¸´ÔÓµÄÖ¬£¨ÀýÈçÈýÖ¬õ£¸ÊÓÍ¡¢¸ÊÓÍÁ×Ö¬¡¢ÇÊÁ×Ö¬ºÍÀ¯£©µÄ³É·Ö¡£
±¥ºÍÖ¬·¾Ëᣨsaturated fatty acid£©£º²»º¬ÓÐ-C£½C-Ë«¼üµÄÖ¬·¾Ëá¡£
²»±¥ºÍÖ¬·¾Ëᣨunsaturated fattyacid£©£ºÖÁÉÙº¬ÓÐÒ»¸ö-C£½C-Ë«¼üµÄÖ¬·¾Ëá¡£
±ØÐèÖ¬·¾Ëᣨossential fattyacids£©£ºÎ¬³Ö²¸È鶯ÎïÕý³£Éú³¤ËùÐèµÄ£¬¶ø¶¯ÎïÓÖ²»ÄܺϳɵÄÖ¬·¾ËᣬÀýÈçÑÇÓÍËáºÍÑÇÂéËá¡£
ÈýÖ¬õ£¸ÊÓÍ£¨triacylglycerol£©£ºÒ²³ÆÖ®¸ÊÓÍÈýõ¥£¨triglyceride£©¡£Ò»ÖÖº¬ÓÐÓë¸ÊÓÍõ¥»¯µÄ3¸öÖ¬õ£»ùµÄÖ¬¡£Ö¬·¾ºÍÓÍÊÇÈýÖ¬õ£¸ÊÓ͵ĻìºÏÎï¡£
Á×Ö¬£¨phospholipid£©£ºº¬ÓÐÁ×Ëá³É·ÖµÄÖ¬¡£ÀýÈçÂÑÁ×Ö¬¡¢ÄÔÁ×Ö¬µÈ¡£
ÇÊÖ¬£¨sphingolipids£©£º
Ò»ÀຬÓÐÇʰ±´¼¹Ç¼ÜµÄÁ½ÐÔÖ¬£¬Ò»¶ËÁ¬½Ó×ÅÒ»¸ö³¤Á´µÄÖ¬·¾ËᣬÁËÒ»¶ËΪһ¸ö¼«ÐԵĴ¼¡£ÇÊÖ¬°üÀ¨ÇÊÁ×Ö¬¡¢ÄÔÁ×Ö¬ÒÔ¼°Éñ¾­½ÚÜÕÖ¬£¬Ò»°ã´æÔÚÓÚÖ²ÎïºÍ¶¯ÎïĤÄÚ£¬ÓÈÆäÊÇÔÚÖÐÊàÉñ¾­ÏµÍ³µÄ×éÖ¯ÄÚº¬Á¿·á¸»¡£
ÇÊÁ×Ö¬£¨sphingomyelin£©£º
Ò»ÖÖÓÉÉñ¾­õ£°·µÄC-1ôÇ»ùÉÏÁ¬½ÓÁËÁ×Ëᵨ¼î£¨»òÁ×ËáÒÒ´¼°·£©¹¹³ÉµÄÇÊÖ¬¡£ÇÊÁ×Ö¬´æÔÚÓÚ´ó¶àÊý²¸È鶯Îïϸ°ûµÄÖÊĤÄÚ£¬ÊÇËèÇʵÄÖ÷Òª³É·Ö¡£
ÂÑÁ×Ö¬£¨lecithin£©£º
¾ÍÊÇÁ×Ö¬õ£µ¨¼î£¨PC£¬phosphatidyl choline£©£¬ÊÇÁ×Ö¬ËáÓ뵨¼îÐγɵÄõ¥¡£
ÄÔÁ×Ö¬£¨cephalin£©£º
¾ÍÊÇÁ×Ö¬õ£ÒÒ´¼°·£¨PE£¬phosphatidyl ethanolamine£©,ÊÇÁ×Ö¬ËáÓëÒÒ´¼°·ÐγɵÄõ¥¡£
Ö¬ÖÊÌ壨liposome£©£ºÊÇÓɰüΧˮÏà¿Õ¼äµÄÁ×֬˫²ãÐγɵÄÄÒÅÝ£¨Ð¡ÅÝ£©¡£
ÉúÎïĤ£¨bioligicalmembrane£©:ÏâǶÓе°°×ÖʵÄ֬˫²ã£¬Æð×Å»®·ÖºÍ·Ö¸ôϸ°ûºÍϸ°ûÆ÷µÄ×÷Óá£ÉúÎïĤҲÊÇÐí¶àÓëÄÜÁ¿×ª»¯ºÍϸ°ûÄÚͨѶÓйصÄÖØÒª²¿Î»¡£
ÄÚÔÚĤµ°°×£¨integral membrane proteins£©£º²åÈë֬˫²ãµÄÊèË®ºËºÍÍêÈ«¿çԽ֬˫²ãµÄĤµ°°×¡£
ÍâÖÜĤµ°°×£¨peripheral membraneproteins£©£ºÍ¨¹ýÓëĤ֬µÄ¼«ÐÔÍ·²¿»òÄÚÔÚĤµ°°×µÄÀë×ÓÏ໥×÷ÓúÍÐγÉÇâ¼üÓëĤµÄÄÚ¡¢Íâ±íÃæÈõ½áºÏµÄĤµ°°×¡£Ä¤µ°°×Ò»µ©´ÓĤÉÏÊͷųöÀ´£¬Í¨³£¶¼ÊÇË®ÈÜÐԵġ£
Á÷ÌåÏâǶģÐÍ(fluid mosaicmodel)£º
Õë¶ÔÉúÎïĤµÄ½á¹¹Ìá³öµÄÒ»ÖÖÄ£ÐÍ¡£ÔÚÕâ¸öÄ£ÐÍÖУ¬ÉúÎïĤ±»ÃèÊö³ÉÏâǶÓе°°×ÖʵÄÁ÷Ìå֬˫²ã£¬Ö¬Ë«²ãÔڽṹºÍ¹¦ÄÜÉ϶¼±íÏÖ³ö²»¶Ô³ÆÐÔ¡£Óеĵ°°×ÖÊ"Ïâ"ÔÚ֬˫²ã±íÃæ£¬ÓеÄÔò²¿·Ö»òÈ«²¿Ç¶ÈëÆäÄÚ²¿£¬ÓеÄÔòºá¿çÕû¸öĤ¡£ÁíÍâÖ¬ºÍĤµ°°×¶¼¿ÉÒÔ½øÐкáÏòÀ©É¢¡£
ͨ͸ϵÊý£¨permeability coefficient£©:ÊÇÀë×Ó»òС·Ö×ÓÀ©É¢¹ý֬˫²ãĤÄÜÁ¦µÄÒ»ÖÖÁ¿¶È¡£
ͨµÀµ°°×£¨channelproteins£©:
ÊÇÒ»ÖÖ´øÓÐÖÐÑëË®ÏàͨµÀµÄÄÚÔÚĤµ°°×£¬Ëü¿ÉÒÔʹ´óСºÏÊʵÄÀë×ӺͷÖ×Ó´ÓĤµÄÈÎÒ»·½Ïò´©¹ýĤ¡£
£¨Ä¤£©¿×µ°°×£¨poreproteins£©:Æäº¬ÒåÓëͨµÀµ°°×ÀàËÆ£¬Ö»ÊǸÃÊõÓï³£ÓÃÓÚϸ¾ú¡£
±»¶¯×ªÔË£¨passivetransport£©£º
Ò²³ÆÖ®Ò×»¯À©É¢£¨facilitateddiffusion£©¡£ÊÇÒ»ÖÖתÔË·½Ê½£¬Í¨¹ý¸Ã·½Ê½ÈÜÖÊÌØÒì½áºÏÓÚÒ»¸öתÔ˵°°×£¬È»ºó±»×ªÔ˹ýĤ£¬µ«×ªÔËÊÇÑØ×ÅŨ¶ÈÌݶÈϽµ·½Ïò½øÐУ¬ËùÒÔ±»¶¯×ªÔ˲»ÐèÒªÄÜÁ¿Ö§³Ö¡£
Ö÷¶¯×ªÔË£¨activetransport£©:
Ò»ÖÖתÔË·½Ê½£¬Í¨¹ý¸Ã·½Ê½ÈÜÖÊÌØÒì½áºÏÓÚÒ»¸öתÔ˵°°×£¬È»ºó±»×ªÔ˹ýĤ£¬µ«Óë±»¶¯×ªÔË·½Ê½Ï෴תÔËÊÇÄæ×ÅŨ¶ÈÌݶȷ½Ïò½øÐеÄ£¬ËùÒÔÖ÷¶¯×ªÔËÐèÒªÄÜÁ¿À´Çý¶¯¡£ÔÚÔ­·¢Ö÷¶¯×ªÔ˹ý³ÌÖУ¬ÄÜÔ´¿ÉÒÔÊǹâ¡¢ATP»òµç×Ó´«µÝ¡£¶øµÚ¶þ¼¶Ö÷¶¯×ªÔËÊÇÔÚÀë×ÓŨ¶ÈÌݶÈÇý¶¯Ï½øÐеÄ¡£
ЭͬÔËËÍ(cotransport)£ºÁ½ÖÖ²»Í¬ÈÜÖÊ¿çĤµÄñîÁª×ªÔË¡£¿ÉÒÔͨ¹ýÒ»¸öתÔ˵°°×½øÐÐͬһ·½Ïò£¨Í¬ÏòתÔË£©»ò·´·½Ïò£¨·´ÏòתÔË£©×ªÔË¡£
°ûÍÌ£¨×÷Óã©£¨endocytosis£©£ºÎïÖʱ»ÖÊĤÍÌÈë²¢ÒÔĤÑÜÉú³öµÄÖ¬ÄÒÅÝÐÎʽ£¨ÎïÖÊÔÚÄÒÅÝÄÚ£©²¢±»´øÈ뵽ϸ°ûÄڵĹý³Ì¡£
°ûÍ£¨×÷Óã©£¨exocytosis£©£ºÈ·¶¨Òª·ÖÃÚµÄÎïÖʱ»°ü¹üÔÚÖ¬ÄÒÅÝÄÚ£¬¸ÃÄÒÅÝÓëÖÊĤÈںϣ¬È»ºó½«ÎïÖÊÊͷŵ½Ï¸°ûÍâ¿Õ¼äµÄ¹ý³Ì¡£
ºËÜÕ£¨nucleoside£©:
ÊÇÓÉàÑßÊ»òà×़î»ùͨ¹ý¹²¼Û¼üÓëÎìÌÇÁ¬½Ó×é³ÉµÄ»¯ºÏÎï¡£ºËÌÇÓë¼î»ùÒ»°ã¶¼ÊÇÓÉÌǵÄÒìͷ̼Óëà×वÄN-1»òàÑßʵÄN-9Ö®¼äÐγɵĦÂ-N-ÌÇÜÕ¼üÁ¬½ÓµÄ¡£
ºËÜÕËᣨnucleotide£©£ººËÜÕµÄÎìÌdzɷÖÖеÄôÇ»ùÁ×ËữÐγɵϝºÏÎï¡£
cAMP£¨cyclicAMP£©:3¨@,5¨@-»·ÏÙÜÕËᣬϸ°ûÄڵĵڶþÐÅʹ£¬ÓÉÓÚijЩ¼¤ËØ»òÆäËü·Ö×ÓÐźŴ̼¤¼¤»îÏÙÜÕËá»·»¯Ã¸´ß»¯ATP»·»¯ÐγɵÄ¡£
Á×Ëá¶þõ¥¼ü£¨phosphodiesterlinkage£©£º
Ò»ÖÖ»¯Ñ§»ùÍÅ£¬Ö¸Ò»·Ö×ÓÁ×ËáÓëÁ½¸ö´¼£¨ôÇ»ù£©õ¥»¯ÐγɵÄÁ½¸öõ¥¼ü¡£¸Ãõ¥¼ü³ÉÁËÁ½¸ö´¼Ö®¼äµÄÇÅÁº¡£ÀýÈçÒ»¸öºËÜÕµÄ3¨@ôÇ»ùÓëÁíÒ»¸öºËÜÕµÄ5¨@ôÇ»ùÓëͬһ·Ö×ÓÁ×Ëáõ¥»¯£¬¾ÍÐγÉÁËÒ»¸öÁ×Ëá¶þõ¥¼ü¡£
ÍÑÑõºËÌǺËËᣨDNA , deoxyribonucleicacid£©:
º¬ÓÐÌØÊâÍÑÑõºËÌǺËÜÕËáÐòÁеľÛÍÑÑõºËÜÕËᣬÍÑÑõºËÜÕËáÖ®¼äÊÇͨ¹ý3¨@,5¨@-Á×Ëá¶þõ¥¼üÁ¬½ÓµÄ¡£DNAÊÇÒÅ´«ÐÅÏ¢µÄÔØÌå¡£
ºËÌǺËËᣨRNA , ribonucleic acid£©:
ͨ¹ý3¨@,5¨@-Á×Ëá¶þõ¥¼üÁ¬½ÓÐγɵÄÌØÊâºËÌǺËÜÕËáÐòÁеľۺËÌǺËÜÕËá¡£
ºËÌÇÌåºËÌǺËËᣨrRNA, ribosomal robonucleicacid£©£º×÷ΪºËÌÇÌå×é³É³É·ÖµÄÒ»ÀàRNA£¬rRNAÊÇϸ°ûÄÚ×î·á¸»µÄRNA¡£
ÐÅʹºËÌǺËËᣨmRNA, messengerribonucleic acid£©£ºÒ»ÀàÓÃ×÷µ°°×ÖʺϳÉÄ£°åµÄRNA¡£
×ªÒÆºËÌǺËËᣨtRNA, transfer ribonucleicacid£©£º
Ò»ÀàЯ´ø¼¤»î°±»ùËᣬ½«Ëü´øµ½µ°°×Öʺϳɲ¿Î»²¢½«°±»ùËáÕûºÏµ½Éú³¤×ŵÄëÄÁ´ÉϵÄRNA¡£tRNAº¬ÓÐÄÜʶ±ðÄ£°åmRNAÉÏ»¥²¹ÃÜÂëµÄ·´ÃÜÂë¡£
ת»¯£¨×÷Óã©£¨transformation£©:Ò»¸öÍâÔ´DNAͨ¹ýijÖÖ;¾¶µ¼ÈëÒ»¸öËÞÖ÷¾ú£¬ÒýÆð¸Ãϸ¾úµÄÒÅ´«ÌØÐԸıäµÄ×÷Óá£
תµ¼£¨×÷Óã©£¨transduction£©:½èÖúÓÚ²¡¶¾ÔØÌ壬ÒÅ´«ÐÅÏ¢´ÓÒ»¸öϸ°û×ªÒÆµ½ÁíÒ»¸öϸ°û¡£
¼î»ù¶Ô£¨basepair£©£ºÍ¨¹ý¼î»ùÖ®¼äÇâ¼üÅä¶ÔµÄºËËáÁ´ÖеÄÁ½¸öºËÜÕËᣬÀýÈçAÓëT»òU£¬ÒÔ¼°GÓëCÅä¶Ô¡£
²é¸ñ·ò·¨Ôò£¨Chargaff'srules£©£ºËùÓÐDNAÖÐÏÙàÑßÊÓëÐØÏÙà×वÄĦ¶ûº¬Á¿ÏàµÈ£¬£¨A£½T£©£¬ÄñàÑßʺͰûà×वÄĦ¶ûº¬Á¿ÏàµÈ£¨G£½C£©£¬¼´àÑßʵÄ×ܺ¬Á¿Óëà×वÄ×ܺ¬Á¿ÏàµÈ£¨A£«G£½T£«C£©¡£DNAµÄ¼î»ù×é³É¾ßÓÐÖÖµÄÌØÒìÐÔ£¬µ«Ã»ÓÐ×éÖ¯ºÍÆ÷¹ÙµÄÌØÒìÐÔ¡£ÁíÍâÉú³¤·¢Óý½×¶Î¡¢ÓªÑø×´Ì¬ºÍ»·¾³µÄ¸Ä±ä¶¼²»Ó°ÏìDNAµÄ¼î»ù×é³É¡£
DNAË«ÂÝÐý(DNA doublehelix)£º
Ò»ÖÖºËËáµÄ¹¹Ïó£¬Ôڸù¹ÏóÖУ¬Á½Ìõ·´ÏòƽÐеĶàºËÜÕËáÁ´Î§ÈƱ˴˲øÈÆÐγÉÒ»¸öÓÒÊÖµÄË«ÂÝÐý½á¹¹¡£¼î»ùλÓÚË«ÂÝÐýÄÚ²à,Á×ËáÓëÌÇ»ùÔÚÍâ²à£¬Í¨¹ýÁ×Ëá¶þõ¥¼üÏàÁ¬,ÐγɺËËáµÄ¹Ç¼Ü¡£¼î»ùÆ½ÃæÓë¼ÙÏëµÄÖÐÐÄÖá´¹Ö±,ÌÇ»·Æ½ÃæÔòÓëÖáÆ½ÐС£Á½ÌõÁ´½ÔΪÓÒÊÖÂÝÐý¡£Ë«ÂÝÐýµÄÖ±¾¶Îª2nm£¬¼î»ù¶Ñ»ý¾àÀëΪ0.34nm£¬Á½ºËÜÕËáÖ®¼äµÄ¼Ð½ÇÊÇ36¡ã£¬Ã¿¶ÔÂÝÐýÓÉ10¶Ô¼î»ù×é³É£¬¼î»ù°´A-T,G-CÅä¶Ô»¥²¹£¬±Ë´ËÒÔÇâ¼üÏàÁ¬Ïµ¡£Î¬³ÖDNAË«ÂÝÐý½á¹¹Îȶ¨µÄÁ¦Ö÷ÒªÊǼî»ù¶Ñ»ýÁ¦¡£Ë«ÂÝÐý±íÃæÓÐÁ½Ìõ¿íÕ­¡¢Éîdz²»Ò»µÄÒ»¸ö´ó¹µºÍÒ»¸öС¹µ¡£
´ó¹µ(major groove)ºÍС¹µ(minorgroove)£º
ÈÆB-DNAË«ÂÝÐý±íÃæÉϳöÏÖµÄÂÝÐý²Û£¨¹µ£©£¬¿íµÄ¹µ³ÆÖ®´ó¹µ£¬Õ­¹µ³ÆÖ®Ð¡¹µ¡£´ó¹µ¡¢Ð¡¹µ¶¼ÊÇÓÉÓÚ¼î»ù¶Ô¶Ñ»ýºÍÌÇ-Á×Ëá¹Ç¼ÜŤתÔì³ÉµÄ¡£
DNA³¬ÂÝÐý£¨DNA supercoiling£©:DNA±¾ÉíµÄ¾íÇú£¬Ò»°ãÊÇDNAË«ÂÝÐýµÄÍäÇú¡¢Ç·Ðý£¨¸º³¬ÂÝÐý£©»ò¹ýÐý£¨Õý³¬ÂÝÐý£©µÄ½á¹û¡£
ÍØÆËÒ칹ø£¨topoisomerase£©:
ͨ¹ýÇжÏDNAµÄÒ»Ìõ»òÁ½ÌõÁ´ÖеÄÁ×Ëá¶þõ¥¼ü£¬È»ºóÖØÐ²øÈƺͷâ¿ÚÀ´¸Ä±äDNAÁ¬»·ÊýµÄø¡£ÍØÆËÒ칹øIͨ¹ýÇжÏDNAÖеÄÒ»ÌõÁ´¼õÉÙ¸º³¬ÂÝÐý£¬Ôö¼ÓÒ»¸öÁ¬»·Êý£»¶øÍØÆËÒ칹øIIÇжÏDNAµÄÁ½ÌõÁ´Ôö¼Ó¸º³¬ÂÝÐý£¬¼õÉÙ2¸öÁ¬»·Êý¡£Ä³Ð©ÍØÆËÒ칹øIIÒ²³ÆÖ®DNA´ÙÐýø¡£
ºËСÌ壨nucleosome£©£ºÓÃÓÚ°üװȾɫÖʵĽṹµ¥Î»£¬ÊÇÓÉDNAÁ´ÈÆÒ»¸ö×éµ°°×ºË²øÈƹ¹³ÉµÄ¡£
ȾɫÖÊ(chromatin)£ºÊÇ´æÔÚÓÚÕæºËÉúÎï¼äÆÚϸ°ûºËÄÚ£¬Ò×±»¼îÐÔȾÁÏ×ÅÉ«µÄÒ»ÖÖÎÞ¶¨ÐÎÎïÖÊ¡£È¾É«ÖÊÖк¬ÓÐ×÷Ϊ¹Ç¼ÜµÄÍêÕûµÄË«Á´DNA£¬ÒÔ¼°×éµ°°×¡¢·Ç×éµ°°×ºÍÉÙÁ¿µÄRNA¡£
ȾɫÌå(chromosome)£º
ÊÇȾɫÖÊÔÚϸ°û·ÖÁѹý³ÌÖо­¹ý½ôÃܲøÈÆ¡¢ÕÛµþ¡¢ÄýËõºÍ¾«Ï¸°ü×°ÐγɵľßÓй̶¨ÐÎ̬µÄÒÅ´«ÎïÖÊ´æÔÚÐÎʽ¡£¼òÑÔÖ®£¬È¾É«ÌåÊÇÒ»¸ö´óµÄµ¥Ò»µÄË«Á´DNA·Ö×ÓÓëÏà¹Øµ°°×ÖÊ×é³ÉµÄ¸´ºÏÎDNAÖк¬ÓÐÐí¶à»ùÒò£¬Öü´æºÍ´«µÝÒÅ´«ÐÅÏ¢¡£
DNA±äÐÔ(DNA denaturation)£ºDNAË«Á´½âÁ´·ÖÀë³ÉÁ½Ìõµ¥Á´µÄÏÖÏó¡£
ÍË»ð£¨annealing£©:¼´DNAÓɵ¥Á´¸´ÐÔ±ä³ÉË«Á´½á¹¹µÄ¹ý³Ì¡£À´Ô´ÏàͬµÄDNAµ¥Á´¾­ÍË»ðºóÍêÈ«»Ö¸´Ë«Á´½á¹¹£¬Í¬Ô´DNAÖ®¼ä¡¢DNAºÍRNAÖ®¼äÍË»ðºóÐγÉÔÓ½»·Ö×Ó¡£
ÈÚ½âζÈ(melting temperature, Tm)£ºË«Á´DNAÈڽ⳹µ×±ä³Éµ¥Á´DNAµÄζȷ¶Î§µÄÖеãζÈ¡£
ÔöɫЧӦ£¨hyperchromic effect£©£ºµ±Ë«ÂÝÐýDNAÈڽ⣨½âÁ´£©Ê±£¬260nm´¦×ÏÍâÎüÊÕÔö¼ÓµÄÏÖÏó¡£
¼õɫЧӦ£¨hypochromic effect£©£ºËæ×źËËḴÐÔ£¬×ÏÍâÎüÊÕ½µµÍµÄÏÖÏó¡£
ºËËáÄÚÇÐø(endonuclease)£ººËÌǺËËáøºÍÍÑÑõºËÌǺËËáøÖÐÄܹ»Ë®½âºËËá·Ö×ÓÄÚÁ×Ëá¶þõ¥¼üµÄø¡£
ºËËáÍâÇÐø(exonuclease)£º´ÓºËËáÁ´µÄÒ»¶ËÖð¸öË®½âϺËÜÕËáµÄø¡£
ÏÞÖÆÐÔÄÚÇÐø£¨restrictionendonucleases£©:Ò»ÖÖÔÚÌØÊâºËÜÕËáÐòÁд¦Ë®½âË«Á´DNAµÄÄÚÇÐø¡£IÐÍÏÞÖÆÐÔÄÚÇÐø¼È´ß»¯ËÞÖ÷DNAµÄ¼×»ù»¯£¬ÓÖ´ß»¯·Ç¼×»ù»¯µÄDNAµÄË®½â£»¶øIIÐÍÏÞÖÆÐÔÄÚÇÐøֻ´ß»¯·Ç¼×»ù»¯µÄDNAµÄË®½â¡£
ÏÞÖÆÃ¸Í¼Æ×(restrictionmap)£º
ͬһDNAÓò»Í¬µÄÏÞÖÆÃ¸½øÐÐÇиî´Ó¶ø»ñµÃ¸÷ÖÖÏÞÖÆÃ¸µÄÇиîλµã£¬Óɴ˽¨Á¢µÄλµãͼÆ×ÓÐÖúÓÚ¶ÔDNAµÄ½á¹¹½øÐзÖÎö¡£
·´ÏòÖØ¸´ÐòÁÐ (inverted repeat sequence)£º
ÔÚͬһ¶àºËÜÕËáÁ´ÄÚµÄÏà·´·½ÏòÉÏ´æÔÚµÄÖØ¸´µÄºËÜÕËáÐòÁС£ÔÚË«Á´DNAÖз´ÏòÖØ¸´¿ÉÄÜÒýÆðÊ®×ÖÐνṹµÄÐγÉ¡£
ÖØ×éDNA¼¼Êõ£¨recombination DNA technology£©:
Ò²³ÆÖ®»ùÒò¹¤³Ì(genomicengineering)¡£ÀûÓÃÏÞÖÆÐÔÄÚÇÐøºÍÔØÌ壬°´ÕÕÔ¤ÏÈÉè¼ÆµÄÒªÇ󣬽«Ò»ÖÖÉúÎïµÄijÖÖÄ¿µÄ»ùÒòºÍÔØÌåDNAÖØ×éºóתÈËÁíÒ»ÉúÎïϸ°ûÖнøÐи´ÖÆ¡¢×ªÂ¼ºÍ±í´ïµÄ¼¼Êõ¡£
»ùÒò£¨gene£©:Ò²³ÆÖ®Ë³·´×Ó£¨cistron£©¡£·ºÖ¸±»×ªÂ¼µÄÒ»¸öDNAƬ¶Î¡£ÔÚijЩÇé¿öÏ£¬»ùÒò³£ÓÃÀ´Ö¸±àÂëÒ»¸ö¹¦Äܵ°°×»òRNA·Ö×ÓµÄDNAƬ¶Î¡£
·Ö½â´úл·´Ó¦£¨catabolicreaction£©:½µ½â¸´ÔÓ·Ö×ÓΪÉúÎïÌåÌṩСµÄ¹¹¼þ·Ö×ÓºÍÄÜÁ¿µÄ´úл·´Ó¦¡£
ºÏ³É´úл·´Ó¦£¨anabolicreaction£©£ººÏ³ÉÓÃÓÚϸ°ûά³ÖºÍÉú³¤ËùÐèÒªµÄ·Ö×ӵĴúл·´Ó¦¡£
·´À¡ÒÖÖÆ£¨feedbackinhibition£©£º´ß»¯Ò»¸ö´úл;¾¶ÖÐÇ°Ãæ·´Ó¦µÄøÊܵ½Í¬Ò»Í¾¾¶µÄÖÕ²úÎïÒÖÖÆµÄÏÖÏó¡£
ǰÀ¡¼¤»î£¨feed-forwardactivation£©£º´úл;¾¶ÖÐÒ»¸öø±»¸Ã;¾¶ÖÐÇ°Ãæ²úÉúµÄ´úлÎD»îµÄÏÖÏó¡£
±ê×¼×ÔÓÉÄܱ仯£¨¦¤G¡ã£©£¨standard free-energy change£©:
ÔÚһϵÁбê×¼Ìõ¼þ£¨Î¶È£º298K£»Ñ¹Á¦£º1¸ö´óÆøÑ¹£»ËùÓÐÈÜÖʵÄŨ¶È¶¼ÊÇ1M£©Ï·¢ÉúµÄ·´Ó¦µÄ×ÔÓÉÄܱ仯¡£¦¤G¡ã¨@±íʾpH7.0Ìõ¼þϵıê×¼×ÔÓÉÄܱ仯¡£
±ê×¼»¹Ô­µç루E¡ã¨@£©£¨standard reductionpotential£©£º
25¡æºÍpH7.0Ìõ¼þÏÂÒ»¸ö»¹Ô­¼ÁºÍËüµÄÑõ»¯ÐÎʽÔÚ1MŨ¶ÈϱíÏÖ³öµÄµç¶¯ÊÆ¡£
½Í½â(glycolysis)£ºÒ»¸öÓÉ10²½Ã¸´Ù·´Ó¦×é³ÉµÄÌÇ·Ö½â´úл;¾¶£¬Í¨¹ý¸Ã;¾¶£¬Ò»·Ö×ÓÆÏÌÑÌÇת»»ÎªÁ½·Ö×Ó±ûͪËᣬͬʱ¾»Éú³ÉÁ½·Ö×ÓATPºÍÁ½·Ö×ÓNADH¡£
·¢½Í(fermentation)£ºÓªÑø·Ö×Ó£¨ÀýÈçÆÏÌÑÌÇ£©²úÄܵÄÑáÑõ½µ½â£¬ÔÚÒÒ´¼·¢½ÍÖУ¬±ûͪËáת»¯ÎªÒÒ´¼ºÍCO2¡£
°Í˹µÂЧӦ(Pasteur effect)£ºÑõ´æÔÚÏ£¬½Í½âËÙ¶È·ÅÂýµÄÏÖÏó¡£
µ×ÎïˮƽÁ×Ëữ(substratephosphorylation)£º
ADP»òijЩÆäËüµÄºËÜÕ-5¨@-¶þÁ×ËáµÄÁ×ËữÊÇͨ¹ýÀ´×ÔÒ»¸ö·ÇºËÜÕËáµ×ÎïµÄÁ×õ£»ùµÄ×ªÒÆÊµÏֵġ£ÕâÖÖÁ×ËữÓëµç×Ó´«µÝÁ´Î޹ء£
ÄûÃÊËáÑ­»·£¨citric acid cycle£©:
Ò²³ÆÖ®ÈýôÈËáÑ­»·(tricarboxylic acid cycle)£¬KrebsÑ­»·£¨Krebscycle£©¡£ÊÇÓÃÓÚÒÒõ£CoAÖеÄÒÒõ£»ùÑõ»¯Éú³ÉCO2µÄø´Ù·´Ó¦µÄÑ­»·ÏµÍ³£¬¸ÃÑ­»·µÄµÚÒ»²½·´Ó¦ÊÇÓÉÒÒõ£CoAºÍ²Ýõ£ÒÒËáËõºÏÐγÉÄûÃÊËá¡£
»Ø²¹·´Ó¦£¨anaplerotic reaction£©£ºÃ¸´ß»¯µÄ²¹³äÄûÃÊËáÑ­»·Öмä´úлÎïµÄ¹©¸øµÄ·´Ó¦£¬ÀýÈçÓɱûͪËáôÈ»¯Éú³É²Ýõ£ÒÒËáµÄ·´Ó¦¡£
ÒÒÈ©ËáÑ­»·£¨glyoxylatecycle£©:
ÊÇijЩֲÎϸ¾úºÍ½ÍĸÖÐÄûÃÊËáÑ­»·µÄÐÞ¸ÄÐÎʽ£¬Í¨¹ý¸ÃÑ­»·¿ÉÒÔÓÉÒÒõ£CoA¾­²Ýõ£ÒÒËá¾»Éú³ÉÆÏÌÑÌÇ¡£ÒÒÈ©ËáÑ­»·ÈƹýÁËÄûÃÊËáÑ­»·ÖÐÉú³ÉÁ½¸öCO2µÄ²½Öè¡£
ÎìÌÇÁ×Ëá;¾¶£¨pentosephosphate pathway£©£º
Ò²³ÆÖ®Á×ËἺÌÇ֧·£¨hexose monophosphateshunt£©¡£ÊÇÒ»¸öÆÏÌÑÌÇ-6-Á×Ëá¾­´úл²úÉúNADPHºÍºËÌÇ-5-Á×ËáµÄ;¾¶¡£¸Ã;¾¶°üÀ¨Ñõ»¯ºÍ·ÇÑõ»¯Á½¸ö½×¶Î£¬ÔÚÑõ»¯½×¶Î£¬ÆÏÌÑÌÇ-6-Á×Ëáת»¯ÎªºËͪÌÇ-5-Á×ËáºÍCO2,²¢Éú³ÉÁ½·Ö×ÓµÄNADPH£»ÔÚ·ÇÑõ»¯½×¶Î£¬ºËͪÌÇ-5-Á×ËáÒì¹¹»¯Éú³ÉºËÌÇ-5-Á×Ëá»òת»¯Îª½Í½âÖеÄÁ½¸öÖмä´úлÎï¹ûÌÇ-6-Á×ËáºÍ¸ÊÓÍÈ©-3-Á×Ëá¡£
ÌÇÈ©Ëá;¾¶(glucuronatepathway)£º
´ÓÆÏÌÑÌÇ-6-Á×Ëá»òÆÏÌÑÌÇ-1-Á×ËῪʼ£¬¾­UDP-ÆÏÌÑÌÇÈ©ËáÉú³ÉÆÏÌÑÌÇÈ©ËáºÍ¿¹»µÑªËáµÄ;¾¶¡£µ«Ö»ÓÐÔÚÖ²ÎïºÍÄÇЩ¿ÉÒԺϳɿ¹»µÑªËᣨάÉúËØC£©¶¯ÎïÌåÄÚ£¬Í¨¹ý¸Ã;¾¶¿ÉÒԺϳÉάÉúËØC¡£
ÎÞЧѭ»·£¨futile cycle£©£º
Ò²³ÆÖ®µ×ÎïÑ­»·£¨substratecycle£©¡£Ò»¶Ô´ß»¯Á½¸ö;¾¶µÄÖмä´úлÎïÖ®¼äÑ­»·µÄ·½ÏòÏà·´¡¢´úлÉϲ»¿ÉÄæµÄ·´Ó¦¡£ÓÐʱ¸ÃÑ­»·Í¨¹ýATPµÄË®½âµ¼ÖÂÈÈÄܵÄÊÍ·Å¡£ÀýÈ磬ÆÏÌÑÌÇ£«ATP£½ÆÏÌÑÌÇ-6-Á×ËᣫADPÓëÆÏÌÑÌÇ-6-Á×ËᣫH2O£½ÆÏÌÑÌÇ£«Pi·´Ó¦×é³ÉµÄÑ­»··´Ó¦£¬Æä¾»·´Ó¦Êµ¼ÊÉÏÊÇATP£«H2O£½ADP£«Pi¡£
Á×Ëá½â£¨×÷Óã©£¨phosphorolysis£©:ÔÚ·Ö×ÓÄÚͨ¹ýÒýÈëÒ»¸öÎÞ»úÁ×ËáÐγÉÁ×Ëáõ¥¼ü¶øÊ¹Ô­À´¼ü¶ÏÁѵķ½Ê½¡£Êµ¼ÊÉÏÒýÈëÁËÒ»¸öÁ×õ£»ù¡£
°ëÈéÌÇѪ֢£¨galactosemia£©:ÈËÀàµÄÒ»ÖÖ»ùÒòÐÍÒÅ´«´úлȱÏÝ£¬ÌصãÊÇÓÉÓÚȱ·¦1-Á×Ëá°ëÈéÌÇÄòÜÕõ£×ªÒÆÃ¸µ¼ÖÂÓ¤¶ù²»ÄÜ´úлÄÌÖ­ÖÐÈéÌÇ·Ö½âÉú³ÉµÄ°ëÈéÌÇ¡£
β²¿Éú³¤£¨tailwardgrowth£©:Ò»Ö־ۺϷ´Ó¦»úÀí£¬¾­¹ý»î»¯µÄµ¥ÌåµÄÍ·²¿½áµ½¾ÛºÏÎïµÄβ²¿£¬Á¬½Óµ½¾ÛºÏÎïβ²¿µÄµ¥ÌåµÄβ²¿ÓÖ³ÉÁ˽ÓÊÕÏÂÒ»¸öµ¥ÌåµÄÊÜÌå¡£
ÌÇÒìÉú×÷ÓÃ(gluconeogenesis)£º
Óɼòµ¥µÄ·ÇÌÇǰÌåת±äΪÌǵĹý³Ì¡£ÌÇÒìÉú²»ÊÇÌǽͽâµÄ¼òµ¥Äæ×ª¡£ËäÈ»ÓɱûͪËῪʼµÄÌÇÒìÉúÀûÓÃÁËÌǽͽâÖеÄ7²½½üËÆÆ½ºâ·´Ó¦µÄÄæ·´Ó¦£¬µ«»¹±ØÐëÀûÓÃÁíÍâ4²½½Í½âÖв»Ôø³öÏֵĸ´Ù·´Ó¦Èƹý½Í½âÖеÄÈý¸ö²»¿ÉÄæ·´Ó¦¡£
ºôÎüµç×Ó´«µÝÁ´£¨respiratory electron-transport chain£©£º
ÓÉһϵÁпÉ×÷Ϊµç×ÓÔØÌåµÄø¸´ºÏÌåºÍ¸¨ÖúÒò×Ó¹¹³É£¬¿É½«À´×Ô»¹Ô­Ð͸¨Ã¸»òµ×ÎïµÄµç×Ó´«µÝ¸øÓÐÑõ´úлµÄ×îÖÕµç×ÓÊÜÌå·Ö×ÓÑõ£¨O2£©¡£
Ñõ»¯Á×Ëữ(oxidativephosphorylation)£º
µç×Ó´ÓÒ»¸öµ×Îï´«µÝ¸ø·Ö×ÓÑõµÄÑõ»¯Óëø´ß»¯µÄÓÉADPºÍPiÉú³ÉATPµÄÁ×ËữÏàżÁªµÄ¹ý³Ì¡£
»¯Ñ§ÉøÍ¸ÀíÂÛ(chemiosmotictheory)£º
Ò»ÖÖѧ˵£¬Ö÷ÒªÂÛµãÊǵ×ÎïÑõ»¯ÆÚ¼ä½¨Á¢µÄÖÊ×ÓŨ¶ÈÌݶÈÌṩÁËÇý¶¯ÓÉADPºÍPiÐγÉATPµÄÄÜÁ¿¡£
¡¡¡¡½âżÁª¼Á£¨uncoupling agent£©:Ò»ÖÖʹµç×Ó´«µÝÓëADPÁ×Ëữ֮¼äµÄ½ôÃÜżÁª¹ØÏµ½â³ýµÄ»¯ºÏÎÀýÈç2,4-¶þÏõ»ù±½·Ó¡£
P/O±È(P/Oratio)£º
ÔÚÑõ»¯Á×ËữÖУ¬Ã¿1/2O2±»»¹Ô­Ê±ÐγɵÄATPµÄĦ¶ûÊý¡£µç×Ó´ÓNADH´«µÝ¸øO2ʱ£¬P/O±ÈΪ3£¬¶øµç×Ó´ÓFADH2´«µÝ¸øO2ʱ£¬P/O±ÈΪ2¡£
¸ßÄÜ»¯ºÏÎï(high energy compound)£ºÔÚ±ê×¼Ìõ¼þÏÂË®½âʱ×ÔÓÉÄÜ´ó·ù¶È¼õÉٵϝºÏÎï¡£Ò»°ãÊÇָˮ½âÊͷŵÄÄÜÁ¿ÄÜÇý¶¯ADPÁ×ËữºÏ³ÉATPµÄ»¯ºÏÎï¡£
Ò¶ÂÌÌ壨chloroplast£©£ºÔåÀàºÍÖ²ÎïÖк¬ÓÐÒ¶ÂÌËØ½øÐйâºÏ×÷ÓÃµÄÆ÷¹Ù¡£
Ò¶ÂÌËØ£¨chlorophyll£©£º¹âºÏ×÷ÓÃĤÖеÄÂÌÉ«É«ËØ£¬ËüÊǹâºÏÉúÎïÖÐÖ÷ÒªµÄ²¶»ñ¹âµÄ³É·Ö¡£
¸¨ÖúÉ«ËØ£¨accessorypigments£©:ÔÚÖ²ÎïºÍ¹âºÏϸ¾úÖÐÏóÀàºúÂܲ·ËØ¡¢Ò¶»ÆËغÍÔ嵨£¨É«£©ËØÄÇÑùÎüÊտɼû¹âµÄÉ«ËØ£¬ÕâÀàÉ«ËØÊǶÔÒ¶ÂÌËØ²¶»ñ¹âÄܵIJ¹³ä¡£
¹âºÏ×÷ÓÃ(photosynthesis)£ºÂÌɫֲÎï»ò¹âºÏϸ¾úÀûÓùâÄܽ«CO2ת»¯³ÉÓлú»¯ºÏÎïµÄ¹ý³Ì¡£
¹âºÏÁ×Ëữ(photophosphorylation)£ºÔÚÒ¶ÂÌÌåATPºÏ³Éø´ß»¯ÏÂÒÀÀµÓÚ¹âµÄÓÉADPºÍPiºÏ³ÉATPµÄ¹ý³Ì¡£
¹â·´Ó¦(light reactions)£º¹âºÏÉ«ËØ½«¹âÄÜת±ä³É»¯Ñ§Äܲ¢ÐγÉATPºÍNADPHµÄ¹ý³Ì¡£
°µ·´Ó¦(darkreactions)£ºÀûÓùⷴӦÉú³ÉµÄATPºÍNADPHµÄ»¯Ñ§ÄÜʹCO2»¹Ô­³ÉÌÇ»òÆäËüÓлúÎïµÄһϵÁÐø´Ù¹ý³Ì¡£
CalvinÑ­»·£¨Cavin cycle£©:
Ò²³ÆÖ®»¹Ô­ÎìÌÇÁ×ËáÑ­»·£¨RPP cycle: reductive pentose phosphatecycle£©£¬C3;¾¶£¨C3 pathway£©¡£ÔÚ¹âºÏ×÷ÓÃÆÚ¼ä£¬½«CO2»¹Ô­×ª»¯ÎªÌǵķ´Ó¦Ñ­»·¡£ÊÇÖ²ÎïÓÃÓڹ̶¨¶þÑõ»¯Ì¼Éú³ÉÁ×Ëá±ûÌǵÄÑ­»·Í¾¾¶¡£
C4;¾¶£¨C4pathway£©£º
һЩֲÎïÖй̶¨Ì¼µÄ;¾¶£¬ÆäÌØµãÊÇͨ¹ýʹCO2ŨËõ¼õÉÙ¹âºôÎü¡£ÔÚ¸Ã;¾¶ÖУ¬ÔÚÒ¶Èâϸ°ûCO2±»ÕûºÏµ½C4ËáÖУ¬È»ºóC4ËáÔÚά¹ÜÊøÇÊϸ°û±»ÍÑôÈ£¬ÊͷųöµÄCO2±»CalvinÑ­»·ÀûÓá£
¹âºôÎü£¨photorespiration£©£º
Ö²ÎïÒÀÀµ¹âÉãÈ¡Ñõ½øÐÐÁ×ËáÒÒ´¼Ëá´úлµÄ¹ý³Ì¡£¹âºôÎüÖ®ËùÒÔ·¢ÉúÊÇÓÉÓÚO2¿ÉÒÔÓëCO2¾ºÕùºËͪÌÇ-1,5-¶þÁ×ËáôÈ»¯Ñõ»¯Ã¸µÄ»îÐÔ²¿Î»¡£
¦ÂÑõ»¯Í¾¾¶(¦Âoxidationpathway)£º
ÊÇÖ¬·¾ËáÑõ»¯·Ö½âµÄÖ÷Ҫ;¾¶£¬Ö¬·¾Ëá±»Á¬ÐøµØÔÚ¦Â̼Ñõ»¯½µ½âÉú³ÉÒÒõ£CoA£¬Í¬Ê±Éú³ÉNADHºÍFADH2£¬Òò´Ë¿É²úÉú´óÁ¿µÄATP¡£¸Ã;¾¶ÒòÍÑÇâºÍÁѽâ¾ù·¢ÉúÔÚ¦Âλ̼ԭ×Ó¶øµÃÃû¡£Ã¿Ò»ÂÖÖ¬·¾Ëá¦ÂÑõ»¯¶¼ÊÇÓÉ4²½·´Ó¦×é³É£ºÑõ»¯¡¢Ë®»¯¡¢ÔÙÑõ»¯ºÍÁò½â¡£
Èâ¶¾¼î´©Ëóϵͳ£¨carnitine shuttle system£©:Ö¬õ£CoAͨ¹ýÐγÉÖ¬õ£Èâ¶¾¼î´Óϸ°ûÖÊתÔ˵½ÏßÁ£ÌåµÄÒ»¸ö´©ËóÑ­»·Í¾¾¶¡£
ͪÌå(acetonebody)£ºÔÚ¸ÎÔàÖÐÓÉÒÒõ£CoAºÏ³ÉµÄȼÁÏ·Ö×Ó£¨¦ÂôÇ»ù¶¡Ëá¡¢ÒÒõ£ÒÒËáºÍ±ûͪ£©¡£ÔÚ¼¢¶öÆÚ¼äͪÌåÊǰüÀ¨ÄÔÔÚÄÚµÄÐí¶à×éÖ¯µÄȼÁÏ£¬ÍªÌå¹ý¶à½«µ¼ÖÂÖж¾¡£
ÄûÃÊËáתÔËϵͳ£¨citrate transportsystem£©:
½«ÒÒõ£CoA´ÓÏßÁ£ÌåתÔ˵½Ï¸°ûÖʵĴ©ËóÑ­»·Í¾¾¶¡£ÔÚתÔËÒÒõ£CoAµÄͬʱ£¬Ï¸°ûÖÊÖеÄNADHÑõ»¯³ÉNAD£«¡¢NADP£«»¹Ô­ÎªNADPH¡£Ã¿Ñ­»·Ò»´ÎÏûºÄ2·Ö×ÓATP¡£
õ£»ùÔØÌåµ°°×£¨ACP, acyl carrierprotein£©£ºÍ¨¹ýÁòõ¥¼ü½áºÏÖ¬·¾ËáºÏ³ÉµÄÖмä´úлÎïµÄµ°°×ÖÊ£¨Ô­ºËÉúÎ»òµ°°×ÖʵĽṹÓò£¨ÕæºËÉúÎ¡£
ÉúÎï¹Ìµª×÷ÓÃ(Biologicalnitrogen fixation)£º´óÆøÖеĵª±»»¹Ô­Îª°±µÄ¹ý³Ì¡£ÉúÎï¹ÌµªÖ»·¢ÉúÔÚÉÙÊýµÄϸ¾úºÍÔåÀàÖС£
ÄòËØÑ­»·£¨ureacycle£©:ÊÇÒ»¸öÓÉ4²½Ã¸´Ù·´Ó¦×é³ÉµÄ¿ÉÒÔ½«À´×Ô°±ºÍÌ춬°±ËáµÄµª×ª»¯ÎªÄòËØµÄ´úлѭ»·¡£¸ÃÑ­»·ÊÇ·¢ÉúÔÚ¼¹×µ¶¯Îï¸ÎÔàÖеÄÒ»¸ö´úлѭ»·¡£
ÍѰ±(deamination)£ºÔÚøµÄ´ß»¯Ï´ÓÉúÎï·Ö×Ó£¨°±»ùËá»òºËÜÕËá·Ö×Ó£©ÖгýÈ¥°±»ùµÄ¹ý³Ì¡£
Ñõ»¯ÍѰ±£¨oxidativedeamination£©£º¦Á-°±»ùËáÔÚøµÄ´ß»¯ÏÂÍѰ±Éú³ÉÏàÓ¦¦Á-ͪËáµÄ¹ý³Ì¡£Ñõ»¯ÍѰ±¹ý³Ìʵ¼ÊÉϰüÀ¨ÍÑÇâºÍË®½âÁ½¸ö²½Öè¡£
ת°±Ã¸£¨transaminases£©£ºÒ²³ÆÖ®°±»ù×ªÒÆÃ¸£¨aminotransferases£©¡£´ß»¯Ò»¸ö¦Á-°±»ùËáµÄ¦Á-°±»ùÏòÒ»¸ö¦Á-ͪËá×ªÒÆµÄø¡£
ת°±(transamination)£ºÒ»¸ö¦Á-°±»ùËáµÄ¦Á-°±»ù½èÖúת°±Ã¸µÄ´ß»¯×÷ÓÃ×ªÒÆµ½Ò»¸ö¦Á-ͪËáµÄ¹ý³Ì¡£
ƹÅÒ·´Ó¦£¨ping-pongreaction£©£º
Ôڸ÷´Ó¦ÖУ¬Ã¸½áºÏÒ»¸öµ×Îï²¢ÊͷųöÒ»¸ö²úÎÁôÏÂÒ»¸öÈ¡´úø£¬È»ºó¸ÃÈ¡´úøÔÙ½áºÏµÚ¶þ¸öµ×ÎïºÍÊͷųöµÚ¶þ¸ö²úÎ×îºóø»Ö¸´µ½ËüµÄÆðʼ״̬¡£
ÉúÌǰ±»ùËá(glucogenic aminoacids)£ºÄÇЩ½µ½âÄÜÉú³É¿É×÷ΪÌÇÒìÉúǰÌå·Ö×Ó£¬ÀýÈç±ûͪËá»òÄûÃÊËáÑ­»·Öмä´úлÎïµÄ°±»ùËá¡£
Éúͪ°±»ùËá(acetonegenicamino acid)£ºÄÇЩ½µ½â¿ÉÉú³ÉÒÒõ£CoA»òͪÌåµÄ°±»ùËá¡£
±½ÍªÄòÖ¢£¨phenylketonuria£©:
ÊÇÓÉÓÚ±½±û°±ËáôÇ»¯Ã¸È±·¦ÒýÆð±½±ûͪËá¶Ñ»ýµÄ´úлÒÅ´«²¡¡£È±·¦±½±û°±ËáôÇ»¯Ã¸£¬±½±û°±ËáÖ»ÄÜ¿¿×ª°±Éú³É±½±ûͪËᣬ²¡ÈËÄòÖÐÅųö´óÁ¿±½±ûͪËá¡£±½±ûͪËá¶Ñ»ý¶ÔÉñ¾­Óж¾º¦£¬ÖÇÁ¦·¢Óý³öÏÖÕϰ­¡£
ÄòºÚËáÖ¢£¨alcaptonuria£©:
ÊÇÀÒ°±Ëá´úлÖÐȱ·¦ÄòºÚËáÑõ»¯Ã¸ÒýÆðµÄ´úлÒÅ´«²¡¡£ÕâÖÖ²¡ÈËÄòÖк¬ÓÐÄòºÚËᣬÔÚ¼îÐÔÌõ¼þϱ©Â¶ÓÚÑõÆøÑõ»¯²¢¾ÛºÏΪÀàËÆÓÚºÚÉ«ËØµÄÎïÖÊ£¬´Ó¶øÊ¹Äò³ÉºÚÉ«¡£
ºËÜÕÁ×Ëữø(nucleosidephosphorylase)£ºÄÜ·Ö½âºËÜÕÉú³Éº¬µª¼îºÍÎìÌǵÄÁ×Ëáõ¥µÄø¡£
ºËÜÕË®½âø(nucleosidehydrolase)£ºÄÜ·Ö½âºËÜÕÉú³Éº¬µª¼îºÍÎìÌǵÄø¡£
´ÓÍ·ºÏ³É(de novo synthesis)£º
ÉúÎïÌåÄÚÓüòµ¥µÄǰÌåÎïÖʺϳÉÉúÎï·Ö×ÓµÄ;¾¶£¬ÀýÈçºËÜÕËáµÄ´ÓÍ·ºÏ³É¡£
²¹¾È;¾¶(salvagepathway)£º
Óë´ÓÍ·ºÏ³É;¾¶²»Í¬£¬ÉúÎï·Ö×ӵĺϳÉ£¬ÀýÈçºËÜÕËá¿ÉÒÔÓɸÃÀà·Ö×Ó½µ½âÐγɵÄÖмä´úлÎÈç¼î»ùµÈÀ´ºÏ³É£¬¸Ã;¾¶ÊÇÒ»¸öÔÙÑ­»·Í¾¾¶¡£
Í´·ç£¨gout£©£º
ÊÇÄòËá¹ýÁ¿Éú²ú»òÄòËáÅÅй²»³ä·ÖÒýÆðµÄÄòËá¶Ñ»ýÔì³ÉµÄ£¬ÄòËá½á¾§¶Ñ»ýÔÚÈí¹Ç¡¢Èí×éÖ¯¡¢ÉöÔàÒÔ¼°¹Ø½Ú´¦¡£Ôڹؽڴ¦µÄ³Á»ý»áÔì³É¾çÁÒµÄÌÛÍ´¡£
±ðàÑßÊ´¼£¨allopurinol£©£ºÊǽṹÉÏ£¨àÑßÊ»·ÉϵÚ7λÊÇC£¬µÚ8λÊÇN£©ÀàËÆÓڴλÆàÑßʵϝºÏÎ¶Ô»ÆàÑßÊÑõ»¯Ã¸ÓкÜÇ¿ÒÖÖÆ×÷Ó㬳£ÓÃÀ´ÖÎÁÆÍ´·ç¡£
×ÔɱÒÖÖÆ×÷Óã¨suicidesubstrate£©£ºµ×ÎïÀàËÆÎᆳø´ß»¯Éú³ÉµÄ²úÎï±ä³ÉÁ˸ÃøµÄÒÖÖÆ¼Á¡£ÀýÈç±ðàÑßÊ´¼¶Ô»ÆàÑßÊÑõ»¯Ã¸µÄÒÖÖÆ¾ÍÊôÓÚÕâÖÖÒÖÖÆÀàÐÍ¡£
Lesch-Nyhan×ÛºÏÖ¢£¨Lesch-Nyhan£©£º
Ò²³ÆÖ®×Ô»ÙÈÝò֢£¬ÊÇÓÉÓڴλÆàÑßÊ-ÄñàÑßÊÁ×ËáºËÌÇ×ªÒÆÃ¸µÄÒÅ´«È±ÏÝÒýÆðµÄ¡£È±·¦¸ÃøʹµÃ´Î»ÆàÑßʺÍÄñàÑßʲ»ÄÜת»»ÎªIMPºÍGMP£¬¶øÊǽµ½âΪÄòËᣬ¹ýÁ¿ÄòËὫµ¼ÖÂLesch-Nyhan×ÛºÏÖ¢¡£
¼¤ËØ£¨hormone£©£ºÒ»ÀàÓÉÄÚ·ÖÃÚ×éÖ¯ºÏ³ÉµÄ΢Á¿µÄ»¯Ñ§ÎïÖÊ£¬ËüÓÉѪҺÔËÊäµ½°Ð×éÖ¯£¬Æð×ÅÒ»¸öÐÅʹµÄ×÷Óõ÷½Ú°Ð×éÖ¯£¨Æ÷¹Ù£©µÄ¹¦ÄÜ¡£
¼¤ËØÊÜÌ壨hormone receptor£©£º
λÓÚϸ°û±íÃæ»òϸ°ûÄÚ½áºÏÌØÒì¼¤ËØ²¢Òý·¢Ï¸°ûÏìÓ¦µÄµ°°×ÖÊ¡£
µÚ¶þÐÅʹ(secondmessenger)£ºÏìÓ¦ÍⲿÐźţ¨µÚÒ»ÐÅʹ£©£¬ÀýÈç¼¤ËØ¶øÔÚϸ°ûÄںϳɵÄЧӦ·Ö×Ó£¬ÀýÈçcAMP¡¢¼¡´¼ÈýÁ×Ëá»ò¶þõ£»ù¸ÊÓ͵È¡£µÚ¶þÐÅʹÔÙÈ¥µ÷½Ú°Ðø£¬ÒýÆðϸ°ûÄÚ¸÷ÖÖЧӦ¡£
¼¶Áª·Å´ó(cascade)£º
ÔÚÌåÄڵIJ»Í¬²¿Î»£¬Í¨¹ýһϵÁеÄø´Ù·´Ó¦À´´«µÝÒ»¸öÐÅÏ¢£¬²¢ÇÒ³õʼÐÅÏ¢ÔÚ´«µ½ÏµÁз´Ó¦µÄ×îºóʱ£¬Ðźŵõ½·Å´ó£¬ÕâÑùµÄÒ»¸öϵÁнÐ×ö¼¶ÁªÏµÍ³¡£×îÆÕͨµÄÀàÐÍÊǵ°°×Ë®½âºÍµ°°×ÖÊÁ×ËữµÄ¼¶Áª·Å´ó¡£
Gµ°°×(Gproteins)£º
ÔÚϸ°ûÄÚÐźŴ«µ¼Í¾¾¶ÖÐÆð×ÅÖØÒª×÷ÓõÄGTP½áºÏµ°°×ÖÊ£¬ÓɦÁ¡¢¦Â¡¢¦ÃÈý¸ö²»Í¬ÑÇ»ù×é³É¡£Óë¼¤ËØÊÜÌå½áºÏµÄÅäÌåÓÕµ¼GTPÓëGµ°°×½áºÏµÄGDP½øÐн»»»£¬½á¹û¼¤»îλÓÚÐźŴ«µ¼Í¾¾¶ÖÐÏÂÓεÄÏÙÜÕËá»·»¯Ã¸¡£Gµ°°×½«°ûÍâµÄµÚÒ»ÐÅʹÉöÉÏÏÙËØµÈ¼¤ËغͰûÄÚµÄÏÙÜÕËá»·»¯Ã¸´ß»¯µÄÏÙÜÕËá»·»¯Éú³ÉµÄµÚ¶þÐÅʹcAMPÁªÏµÆðÀ´¡£Gµ°°×¾ßÓÐÄÚÔ´GTPø»îÐÔ¡£
¼¤ËØÐ§Ó¦Ôª¼þ£¨hormone response elements,HRE£©£º
ÊÇÖ¸Àà¹Ì´¼¡¢¼××´ÏÙËØµÈ¼¤ËØÊÜÌå½áºÏµÄÒ»¶Î¶ÌµÄDNAÐòÁУ¨12¡«20bp£©£¬ÕâÀàÊÜÌå½áºÏDNAºó¿É¸Ä±äÏàÁÚ»ùÒòµÄ±í´ï¡£
°ë±£Áô¸´ÖÆ(semiconservativereplication)£º
DNA¸´ÖƵÄÒ»ÖÖ·½Ê½¡£Ã¿ÌõÁ´¶¼¿ÉÓÃ×÷ºÏ³É»¥²¹Á´µÄÄ£°å£¬ºÏ³É³öÁ½·Ö×ÓµÄË«Á´DNA£¬Ã¿¸ö·Ö×Ó¶¼ÊÇÓÉÒ»ÌõÇ×´úÁ´ºÍÒ»ÌõкϳɵÄÁ´×é³É¡£
¸´ÖƲ棨replication forks£©£ºY×ÖÐͽṹ£¬ÔÚ¸´ÖƲ洦×÷Ϊģ°åµÄË«Á´DNA½âÐý£¬Í¬Ê±ºÏ³ÉеÄDNAÁ´¡£
DNA¾ÛºÏø£¨DNA polymerase£©£º
ÒÔDNAΪģ°å´ß»¯ºËÜÕËá²Ð»ù¼Óµ½ÒÑ´æÔڵľۺËÜÕËáµÄ3¨@Ä©¶Ë·´Ó¦µÄø¡£Ä³Ð©DNA¾ÛºÏø¾ßÓÐÍâÇкËËáøµÄ»îÐÔ£¬¿ÉÓÃÀ´Ð£ÕýкϳɵĺËÜÕËáÐòÁС£
KlenowƬ¶Î(Klenow fragment)£º
E.coli DNA¾ÛºÏøI¾­²¿·ÖË®½âÉú³ÉµÄCÄ©¶Ë605¸ö°±»ùËá²Ð»ùƬ¶Î¡£¸ÃƬ¶Î±£ÁôÁËDNA¾ÛºÏøIµÄ5¨@-3¨@¾ÛºÏøºÍ3¨@-5¨@ÍâÇÐø»îÐÔ£¬µ«È±ÉÙÍêÕûøµÄ5¨@-3¨@ÍâÇÐø»îÐÔ¡£
ǰµ¼Á´£¨leadingstrand£©£ºÓë¸´ÖÆ²æÒƶ¯µÄ·½ÏòÒ»Ö£¬Í¨¹ýÁ¬ÐøµØ5¨@¡ú3¨@¾ÛºÏºÏ³ÉµÄеÄDNAÁ´¡£
ÖͺóÁ´£¨laggingstrand£©£ºÓë¸´ÖÆ²æÒƶ¯µÄ·½ÏòÏà·´£¬Í¨¹ý²»Á¬ÐøµØ5¨@¡ú3¨@¾ÛºÏºÏ³ÉµÄеÄDNAÁ´¡£
¸ÔÆéƬ¶Î(Okazakifragments)£º
Ïà¶Ô±È½Ï¶ÌµÄDNAÁ´£¨´óÔ¼1000ºËÜÕËá²Ð»ù£©£¬ÊÇÔÚDNAµÄÖͺóÁ´µÄ²»Á¬ÐøºÏ³ÉÆÚ¼äÉú³ÉµÄƬ¶Î£¬ÕâÊÇReiji OkazakiÔÚDNAºÏ³ÉʵÑéÖÐÌí¼Ó·ÅÉäÐÔµÄÍÑÑõºËÜÕËáǰÌå¹Û²ìµ½µÄ¡£
Òý·¢Ì壨primosome£©:Ò»Öֶ൰°×¸´ºÏÌ壬E.coliÖеÄÒý·¢Ìå°üÀ¨´ß»¯ÖͺóÁ´²»Á¬ÐøDNAºÏ³ÉËùÐèÒªµÄ¶ÌµÄRNAÒýÎïºÏ³ÉµÄÒý·¢Ã¸¡¢½âÐýø¡£
¸´ÖÆÌå(replisome)£ºÒ»Öֶ൰°×¸´ºÏÌ壬°üº¬DNA¾ÛºÏø¡¢Òý·¢Ã¸¡¢½âÐýø¡¢µ¥Á´½áºÏµ°°×ºÍÆäËü¸¨ÖúÒò×Ó¡£¸´ÖÆÌåλÓÚÿ¸ö¸´ÖƲ洦ִÐÐ×Åϸ¾úȾɫÌåDNA¸´ÖƵľۺϷ´Ó¦¡£
µ¥Á´½áºÏµ°°×£¨SSB£¬single-strand bindingprotein£©:
Ò»ÖÖÓëµ¥Á´DNA½áºÏ½ôÃܵĵ°°×ÖÊ£¬ËüµÄ½áºÏ¿ÉÒÔ·ÀÖ¹¸´ÖƲ洦µÄµ¥Á´DNA±¾ÉíÖØÐÂÕÛµþ»ØË«Á´Çø¡£
¹ö»·¸´ÖÆ£¨rolling-circlereplication£©£º
¸´ÖÆ»·×´DNAµÄÒ»ÖÖģʽ£¬ÔÚ¸ÃģʽÖУ¬DNA¾ÛºÏø½áºÏÔÚÒ»¸öȱ¿ÚÁ´µÄ3¨@¶Ë£¬ÈÆ»·ºÏ³ÉÓëÄ£°åÁ´»¥²¹µÄDNA£¬Ã¿Ò»ÂÖ¶¼ÊÇкϳɵÄDNAÈ¡´úǰһÂֺϳɵÄDNA¡£
Äæ×ªÂ¼Ã¸£¨reversetranscriptase£©:
Ò»ÖÖ´ß»¯ÒÔRNAΪģ°åºÏ³ÉDNAµÄDNA¾ÛºÏø£¬¾ßÓÐRNAÖ¸µ¼µÄDNAºÏ³É¡¢Ë®½âRNAºÍDNAÖ¸µ¼µÄDNAºÏ³ÉµÄø»îÐÔ¡£
»¥²¹DNA (cDNA , complementary DNA)£ºÍ¨¹ýÄæ×ªÂ¼Ã¸ÓÉmRNAÄ£°åºÏ³ÉµÄË«Á´DNA¡£
¾ÛºÏøÁ´Ê½·´Ó¦£¨PCR, polymerase chainreaction£©:
À©ÔöÑùÆ·ÖеÄDNAÁ¿ºÍ¸»¼¯ÖÚ¶àDNA·Ö×ÓÖеÄÒ»¸öÌØ¶¨DNAÐòÁеÄÒ»ÖÖ¼¼Êõ¡£Ôڸ÷´Ó¦ÖУ¬Ê¹ÓÃÓëÄ¿µÄDNAÐòÁл¥²¹µÄ¹ÑºËÜÕËá×÷ΪÒýÎ½øÐжàÂÖµÄDNAºÏ³É¡£ÆäÖаüÀ¨DNA±äÐÔ¡¢ÒýÎïÍË»ðºÍÔÚTaqDNA¾ÛºÏø´ß»¯ÏµÄDNAºÏ³É¡£
Ö±½ÓÐÞ¸´£¨directrepair£©:
ÊÇͨ¹ýÒ»ÖÖ¿ÉÁ¬ÐøÉ¨ÃèDNA£¬Ê¶±ð³öËðÉ˲¿Î»µÄµ°°×Öʽ«ËðÉ˲¿Î»Ö±½ÓÐÞ¸´µÄ·½·¨¡£¸ÃÐÞ¸´·½·¨²»ÓÃÇжÏDNA»òÇгý¼î»ù¡£
ÇгýÐÞ¸´£¨excisionrepair£©:
ͨ¹ýÇгý-ÐÞ¸´ÄÚÇÐøʹDNAËðÉËÏû³ýµÄÐÞ¸´·½·¨¡£Ò»°ãÊÇÇÐÈ¥ËðÉËÇø£¬È»ºóÔÚDNA¾ÛºÏøµÄ×÷ÓÃÏÂÒÔ¶³öµÄµ¥Á´ÎªÄ£°åºÏ³ÉÐµĻ¥²¹Á´£¬×îºóÓÃÁ¬½Óø½«È±¿ÚÁ¬½ÓÆðÀ´¡£
´íÅäÐÞ¸´£¨mismatchrepair£©:
ÔÚº¬ÓдíÅä¼î»ùµÄDNA·Ö×ÓÖÐʹÕý³£ºËÜÕËáÐòÁлָ´µÄÐÞ¸´·½Ê½¡£ÕâÖÖÐÞ¸´·½Ê½µÄÌØµãÊÇ£ºÊ¶±ð³öÕýÈ·µÄÁ´£¬Çгýµô²»ÕýÈ·Á´µÄ²¿·Ö£¬È»ºóͨ¹ýDNA¾ÛºÏøºÍDNAÁ¬½ÓøµÄ×÷ÓúϳÉÕýÈ·Åä¶ÔµÄË«Á´DNA¡£
ÒÅ´«Ñ§ÖÐÐÄ·¨Ôò£¨genetic centraldogma£©:
ÃèÊö´ÓÒ»¸ö»ùÒòµ½ÏàÓ¦µ°°×ÖʵÄÐÅÏ¢Á÷µÄ;¾¶¡£ÒÅ´«ÐÅÏ¢Öü´æÔÚDNAÖУ¬DNA±»¸´ÖÆ´«¸ø×Ó´úϸ°û£¬ÐÅÏ¢±»¿½±´»òÓÉDNA±»×ªÂ¼³ÉRNA£¬È»ºóRNA±»·­Òë³É¶àëÄÁ´¡£²»¹ýÓÉÓÚÄæ×ªÂ¼Ã¸µÄ·¢ÏÖ£¬Ò²¿ÉÒÔÒÔRNAΪģ°åºÏ³ÉDNA¡£
ת¼£¨transcription£©:ÔÚÓÉRNA¾ÛºÏøºÍ¸¨ÖúÒò×Ó×é³ÉµÄת¼¸´ºÏÌåµÄ´ß»¯Ï£¬´ÓË«Á´DNA·Ö×ÓÖп½±´ÉúÎïÐÅÏ¢Éú³Éµ¥Ò»Ò»ÌõRNAÁ´µÄ¹ý³Ì¡£
Ä£°åÁ´(template strand)£º
¿É×÷Ϊģ°åת¼ΪRNAµÄÄÇÌõÁ´£¬¸ÃÁ´Óëת¼µÄRNA¼î»ù»¥²¹£¨A-U,G-C£©¡£ÔÚת¼¹ý³ÌÖУ¬RNA¾ÛºÏøÓëÄ£°åÁ´½áºÏ£¬²¢ÑØ×ÅÄ£°åÁ´µÄ3¨@¡ú5¨@·½ÏòÒÆ¶¯£¬°´ÕÕ5¨@¡ú3¨@·½Ïò´ß»¯RNAµÄºÏ³É¡£
±àÂëÁ´£¨codingstrand£©£ºË«Á´DNAÖУ¬²»ÄܽøÐÐת¼µÄÄÇÌõDNAÁ´,¸ÃÁ´µÄºËÜÕËáÐòÁÐÓëת¼Éú³ÉµÄRNAµÄÐòÁÐÒ»Ö£¨ÔÚRNAÖÐÊÇÒÔUÈ¡´úÁËDNAÖеÄT£©¡£
ºËÐÄø(coreenzyme)£º
´ó³¦¸Ë¾úµÄRNA¾ÛºÏøȫøÓÉÎå¸öÑÇ»ù£¨¦Á2¦Â¦Â'¦Ä£©×é³É£¬Ã»ÓЦÄÑÇ»ùµÄø½ÐºËÐÄø¡£ºËÐÄøֻÄÜʹÒÑ¿ªÊ¼ºÏ³ÉµÄRNAÁ´ÑÓ³¤£¬µ«²»¾ßÓÐÆðʼºÏ³ÉRNAµÄÄÜÁ¦£¬±ØÐè¼ÓÈë¦ÄÑÇ»ù²Å±íÏÖ³öÈ«²¿¾ÛºÏøµÄ»îÐÔ¡£
RNA¾ÛºÏø(RNA polymerase)£ºÒÔÒ»ÌõDNAÁ´»òRNAΪģ°å´ß»¯ÓɺËÜÕ-5¨@-ÈýÁ×ËáºÏ³ÉRNAµÄø¡£
Æô¶¯×Ó£¨promoter£©: NA·Ö×ÓÖÐRNA¾ÛºÏøÄܹ»½áºÏ²¢µ¼ÖÂת¼ÆðʼµÄÐòÁС£
ÄÚº¬×Ó£¨introns£©£ºÔÚת¼ºóµÄ¼Ó¹¤ÖУ¬´Ó×î³õµÄת¼²úÎï³ýÈ¥µÄÄÚ²¿µÄºËÜÕËáÐòÁС£ÊõÓïÄÚº¬×ÓÒ²Ö¸±àÂëÏàÓ¦RNAÄÚº¬×ÓµÄDNAÖеÄÇøÓò¡£
ÍâÏÔ×Ó£¨exons£©£º¼È´æÔÚÓÚ×î³õµÄת¼²úÎïÖУ¬Ò²´æÔÚÓÚ³ÉÊìµÄRNA·Ö×ÓÖеĺËÜÕËáÐòÁС£ÊõÓïÍâÏÔ×ÓÒ²Ö¸±àÂëÏàÓ¦RNAÍâÏÔ×ÓµÄDNAÖеÄÇøÓò¡£
ÖÕÖ¹Òò×Ó(termination factors)£ºÐ­ÖúRNA ¾ÛºÏøʶ±ðÖÕÖ¹Ðźŵĸ¨ÖúÒò×Ó£¨µ°°×ÖÊ£©¡£
ºËø£¨ribozymes£©£º¾ßÓÐÏóøÄÇÑù´ß»¯¹¦ÄܵÄRNA·Ö×Ó¡£
¼ô½ÓÌ壨spliceosome£©:´óµÄµ°°×ÖÊ-RNA¸´ºÏÌ壬Ëü´ß»¯ÄÚº¬×Ó´ÓmRNAǰÌåÖгýÈ¥µÄ·´Ó¦¡£
RNA¼Ó¹¤¹ý³Ì£¨RNAprocessing£©£º
½«Ò»¸öRNAÔ­³õת¼²úÎïת»»³É³ÉÊìRNA·Ö×ӵķ´Ó¦¹ý³Ì¡£¼Ó¹¤°üÀ¨´ÓÔ­³õת¼²úÎïÖÐɾ³ýһЩºËÜÕËᣬÌí¼ÓһЩ»ùÒòûÓбàÂëµÄºËÜÕËᣬºÍ¶ÔijЩ¼î»ù½øÐй²¼ÛÐÞÊΡ£
RNA¼ô½Ó£¨RNAsplicing£©£º´ÓDNAÄ£°åÁ´×ªÂ¼³öµÄ×î³õת¼²úÎïÖгýÈ¥ÄÚº¬×Ó£¬²¢½«ÍâÏÔ×ÓÁ¬½ÓÆðÀ´ÐγÉÒ»¸öÁ¬ÐøµÄRNA·Ö×ӵĹý³Ì¡£
·­Ò루translation£©£ºÔÚµ°°×ÖÊºÏ³ÉÆÚ¼ä½«´æÔÚÓÚmRNAÉÏ´ú±íÒ»¸ö¶àëÄÁ´µÄºËÜÕËá²Ð»ùÐòÁÐת»»Îª¶àëÄÁ´°±»ùËá²Ð»ùÐòÁеĹý³Ì¡£
ÒÅ´«ÃÜÂ루geneticcode£©:
ºËËáÖеĺËÜÕËá²Ð»ùÐòÁÐÓëµ°°×ÖÊÖеݱ»ùËá²Ð»ùÐòÁÐÖ®¼äµÄ¶ÔÓ¦¹ØÏµ¡£Á¬ÐøµÄ3¸öºËÜÕËá²Ð»ùÐòÁÐΪһ¸öÃÜÂë£¬ÌØÖ¸Ò»¸ö°±»ùËá¡£±ê×¼µÄÒÅ´«ÃÜÂëÊÇÓÉ64¸öÃÜÂë×é³ÉµÄ£¬¼¸ºõΪËùÓÐÉúÎïͨÓá£
ÆðʼÃÜÂ루iniation codon£©£ºÖ¸¶¨µ°°×ÖÊºÏ³ÉÆðʼλµãµÄÃÜÂë¡£×î³£¼ûµÄÆðʼÃÜÂëÊǵ°°±ËáÃÜÂ룺AUG¡£
ÖÕÖ¹ÃÜÂ루terminationcodon£©£º
ÈκÎtRNA·Ö×Ó¶¼²»ÄÜÕý³£Ê¶±ðµÄ¡¢µ«¿É±»ÌØÊâµ°°×½áºÏ²¢ÒýÆðкϳɵÄëÄÁ´´Ó·­Òë»úÆ÷ÉÏÊͷŵÄÃÜÂë¡£´æÔÚÈý¸öÖÕÖ¹ÃÜÂ룺UAG£¬UAAºÍUGA¡£
ÃÜÂë×Ó(codon)£º
mRNA£¨»òDNA£©ÉϵÄÈýÁªÌåºËÜÕËá²Ð»ùÐòÁУ¬¸ÃÐòÁбàÂë×ÅÒ»¸öÖ¸¶¨µÄ°±»ùËᣬtRNAµÄ·´ÃÜÂë×ÓÓëmRNAµÄÃÜÂë×Ó»¥²¹¡£
·´ÃÜÂë×Ó£¨anticodon£©:
tRNA·Ö×ӵķ´ÃÜÂë»·ÉϵÄÈýÁªÌåºËÜÕËá²Ð»ùÐòÁС£ÔÚ·­ÒëÆÚ¼ä£¬·´ÃÜÂëÓëmRNAÖеĻ¥²¹ÃÜÂë½áºÏ¡£
¼ò²¢ÃÜÂë×Ó(degenerate codon)£º
Ò²³ÆÖ®Í¬ÒåÃÜÂë×Ó£¨synonymouscodon£©¡£ÊÇÖ¸±àÂëÏàͬ°±»ùËáµÄ¼¸¸ö²»Í¬µÄÃÜÂë×Ó¡£
°±»ùËá±Û£¨amino arm£©:Ò²³ÆÖ®½ÓÄɾ¥£¨acceptorstem£©¡£tRNA·Ö×ÓÖп¿½ü3¨@¶ËµÄºËÜÕËáÐòÁкÍ5¨@¶ËµÄÐòÁмî»ùÅä¶Ô£¬ÐγɵĿɽÓÊÕ°±»ùËáµÄ±Û£¨¾¥£©¡£
T¦×C±Û£¨T¦×Carm£©£ºtRNAÖк¬ÓÐÐØÏÙà×ऺËÜÕËá-¼ÙÄòà×ऺËÜÕËá-°ûà×ऺËÜÕËá²Ð»ùÐòÁеľ¥»·½á¹¹¡£
°±õ£-tRNA£¨aminoacyl-tRNA£©£ºÔÚ°±»ùËá±ÛµÄ3¨@¶ËµÄÏÙÜÕËá²Ð»ù¹²¼ÛÁ¬½ÓÁ˰±»ùËáµÄtRNA·Ö×Ó¡£
ͬ¹¤tRNA£¨isoacceptor tRNA£©£º½áºÏÏàͬ°±»ùËáµÄ²»Í¬µÄtRNA·Ö×Ó¡£
°Ú¶¯(wobble)£º
´¦ÓÚÃÜÂë×Ó3¨@¶ËµÄ¼î»ùºÍÓëÖ®»¥²¹µÄ·´ÃÜÂëµÄ5¨@¶ËµÄ¼î»ùÖ®¼äµÄ¼î»ùÅä¶ÔÓÐÒ»¶¨µÄ¿íÈÝÐÔ£¬¼´´¦ÓÚ·´ÃÜÂëµÄ5¨@¶ËµÄ¼î»ù£¨Ò²³ÆÖ®°Ú¶¯Î»Öã©£¬ÀýÈçI¿ÉÒÔÓëÃÜÂë×ÓÉÏ3¨@¶ËµÄU¡¢CºÍAÅä¶Ô¡£ÓÉÓÚ´æÔÚ°Ú¶¯ÏÖÏóËùÒÔʹµÃÒ»¸ötRNA·´ÃÜÂë×Ó¿ÉÒÔºÍÒ»¸öÒÔÉϵÄmRNAÃÜÂë×Ó½áºÏ¡£
°±õ£-tRNAºÏ³Éø£¨aminoacyl-tRNA synthetase£©£º
´ß»¯Ìض¨°±»ùËἤ»î²¢¹²¼Û½áºÏÔÚÏàÓ¦µÄtRNA·Ö×Ó3¨@¶ËµÄø¡£
·­ÒëÆðʼ¸´ºÏÌ壨translation initiationcomplex£©£ºÓɺËÌÇÌåÑÇ»ù¡¢Ò»¸ömRNAÄ£°å¡¢Ò»¸öÆðʼµÄtRNA·Ö×ÓºÍÆðʼÒò×Ó×é³É²¢×é×°ÔÚµ°°×ÖÊºÏ³ÉÆðʼµãµÄ¸´ºÏÌå¡£
¶ÁÂë¿ò( reading frame)£º´ú±íÒ»¸ö°±»ùËáÐòÁеÄmRNA·Ö×ӵķÇÖØµþÃÜÂëÐòÁС£Ò»¸ömRNAµÄ¶ÁÂë¿òÊÇÓÉת¼ÆðʼλÖã¨Í¨³£ÊÇAUGÃÜÂ룩ȷ¶¨µÄ¡£
SDÐòÁУ¨Shine-Dalgarno sequence£©£ºmRNAÖÐÓÃÓÚ½áºÏÔ­ºËÉúÎïºËÌÇÌåµÄÐòÁС£
ëÄõ£×ªÒÆÃ¸£¨peptidyltransferase£©£ºµ°°×ÖÊºÏ³ÉÆÚ¼ä¸ºÔð×ªÒÆëÄõ£»ùºÍ´ß»¯ëļüÐγɵÄø¡£
àÑßÊÃ¹ËØ£¨puromycin£©£ºÍ¨¹ýÕûºÏµ½Éú³¤×ŵÄëÄÁ´£¬ÒýÆðëÄÁ´ºÏ³ÉÌáǰÖÕÖ¹À´ÒÖÖÆ¶àëÄÁ´ºÏ³ÉµÄÒ»ÖÖ¿¹ÉúËØ¡£
¿ª·Å¶ÁÂë¿ò(openreading frame)£ºDNA »òRNAÐòÁÐÖÐÒ»¶Î²»º¬ÖÕÖ¹ÃÜÂëµÄÁ¬ÐøµÄ·ÇÖØµþºËÜÕËáÃÜÂë¡£
ÐźÅëÄ£¨signalpeptide£©:³£Ö¸ÐºϳɶàëÄÁ´ÖÐÓÃÓÚÖ¸µ¼µ°°×ÖÊ¿çÄ¤×ªÒÆ£¨¶¨Î»£©µÄN-Ä©¶ËµÄ°±»ùËáÐòÁУ¨ÓÐʱ²»Ò»¶¨ÔÚN¶Ë£©¡£
ת¼Òò×Ó£¨transcriptionfactor£©£º
ÔÚת¼Æðʼ¸´ºÏÌåµÄ×é×°¹ý³ÌÖУ¬ÓëÆô¶¯×ÓÇø½áºÏ²¢ÓëRNA¾ÛºÏøÏ໥×÷ÓõÄÒ»ÖÖµ°°×ÖÊ¡£Ä³Ð©×ªÂ¼Òò×ÓÔÚRNAÑÓÉìʱһֱά³Ö׎áºÏ״̬¡£
²Ù×Ý×Ó£¨operons£©:ÊÇÓÉÒ»¸ö»ò¶à¸öÏà¹Ø»ùÒòÒÔ¼°µ÷¿ØËüÃÇת¼µÄ²Ù×Ý»ùÒòºÍÆô¶¯×ÓÐòÁÐ×é³ÉµÄ»ùÒò±í´ïµ¥Î»¡£
²Ù×Ý»ùÒò£¨operator£©£ºÓëÌØ¶¨×è¶ôµ°°×Ï໥×÷Óõ÷¿ØÒ»¸ö»ùÒò»òÒ»×é»ùÒò±í´ïµÄDNAÇø¡£
½á¹¹»ùÒò£¨structuralgene£©£º±àÂëÒ»¸öµ°°×ÖÊ»òÒ»¸öRNAµÄ»ùÒò¡£
ת¼¼¤»î¼Á£¨transcriptionalactivator£©£ºÍ¨¹ýÔö¼ÓRNA¾ÛºÏøµÄ»îÐÔÀ´¼Ó¿ìת¼ËٶȵÄÒ»ÖÖµ÷½ÚDNA½áºÏµ°°×¡£
×è¶ôÎrepressor£©£ºÓëÒ»¸ö»ùÒòµÄµ÷¿ØÐòÁлò²Ù×Ý»ùÒò½áºÏÒÔ×èÖ¹¸Ã»ùÒòת¼µÄÒ»À൰°×ÖÊ¡£
Ë¥¼õ×÷Óã¨attenuation£©£ºÒ»ÖÖ·­Òëµ÷¿Ø»úÖÆ¡£ÔڸûúÖÆÖУ¬ºËÌÇÌåÑØ×ÅmRNA·Ö×ÓµÄÒÆ¶¯µÄËÙÂʾö¶¨×ªÂ¼ÊǽøÐл¹ÊÇÖÕÖ¹¡£
ÁÁ°±ËáÀ­Á´£¨leucinezipper£©:
³öÏÖÔÚDNA½áºÏµ°°×ÖÊºÍÆäËüµ°°×ÖÊÖеÄÒ»Öֽṹ»ùÔª£¨motif£©¡£µ±À´×Ôͬһ¸ö»ò²»Í¬¶àëÄÁ´µÄÁ½¸öÁ½ÐԵĦÁ-ÂÝÐýµÄÊèË®Ãæ£¨³£³£º¬ÓÐÁÁ°±Ëá²Ð»ù£©Ï໥×÷ÓÃÐγÉÒ»¸öȦ¶ÔȦµÄ¶þ¾ÛÌå½á¹¹Ê±¾ÍÐγÉÁËÁÁ°±ËáÀ­Á´¡£
пָ£¨zincfinger£©£ºÒ²ÊÇÒ»ÖÖ³£³öÏÖÔÚDNA½áºÏµ°°×ÖÊÖеÄÒ»Öֽṹ»ùÔª¡£ÊÇÓÉÒ»¸öº¬ÓдóÔ¼30¸ö°±»ùËá²Ð»ùµÄ»·ºÍÒ»¸öÓë»·ÉϵÄ4¸öCys»ò2¸öCysºÍ2¸öHisÅäλµÄZn2£«¹¹³É£¬ÐγɵĽṹÏó¸öÊÖָ״¡£
---------------------------------
´«ËµÖеÄɳ·¢£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡°¡¹þ¹þ
---------------------------------
лл¥Ö÷°¡
---------------------------------
лл,¶¥Ò»ÏÂ.
---------------------------------
лл¥סÁË ÐÁ¿àÁË

---------------------------------
лл·ÖÏí
---------------------------------
ÕæÐÄлл¥Ö÷.
---------------------------------
dingding
---------------------------------
лл¥zhuÁË ÐÁ¿àÁË
---------------------------------
Õæ¹»¶àµÄ£¬Ð»Ð»

Ïà¹Ø»°Ìâ/

  • ÁìÏÞʱ´ó¶îÓÅ»Ýȯ,Ïí±¾Õ¾Õý°æöλÔÓéÀֵǼÈë¿ÚÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ!
    ´ó¶îÓÅ»Ýȯ
    ÓÅ»ÝȯÁìÈ¡ºó72СʱÄÚÓÐЧ£¬10ÍòÖÖ×îÐÂöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿¼Ö¤Ààµç×Ó´òÓ¡öλÔÓéÀÖ¹Ù·½appÏÂÔØÈÎÄãÑ¡¡£º­¸ÇÈ«¹ú500ÓàËùԺУöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿Î¡¢200¶àÖÖÖ°Òµ×ʸñöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¡¢1100¶àÖÖ¾­µä½Ì²Ä£¬²úÆ·ÀàÐͰüº¬µç×ÓÊé¡¢Ìâ¿â¡¢È«Ì×öλÔÓéÀÖ¹Ù·½appÏÂÔØÒÔ¼°ÊÓÆµ£¬ÎÞÂÛÄúÊÇöλÔÓéÀÖ¹Ù·½appÏÂÔØ¸´Ï°¡¢¿¼Ö¤Ë¢Ì⣬»¹ÊÇ¿¼Ç°³å´ÌµÈ£¬²»Í¬ÀàÐ͵IJúÆ·¿ÉÂú×ãÄúѧϰÉϵIJ»Í¬ÐèÇó¡£ ...
    öλÔÓéÀֵǼÈë¿ÚÏÂÔØÓÅ»Ýȯ ±¾Õ¾Ð¡±à FreeÒ¼°Û·ÖÑ§Ï°Íø 2022-09-19
öλÔÓéÀÖ(xinhui)¹Ù·½ÍøÕ¾_öλÔÓéÀÖappÏÂÔØÈë¿Ú